Vaccine and Vaccination — MCQs

Q: Inactivated microorganisms are used in the manufacture of which of the following vaccines?

Salk vaccine. **Explanation:** The core concept tested here is the classification of vaccines based on the state of the immunizing agent. **1. Why Salk Vaccine is Correct:** The **Salk vaccine (IPV - Inactivated Poliovirus Vaccine)** is a classic example of a **killed/inactivated vaccine**. In these vaccines, the microorganism (in this case, Poliovirus types 1, 2, and 3) is grown in culture and then killed using heat or chemicals (usually formaldehyde). While the virus can no longer replicate, its structural proteins remain intact to trigger an immune response, primarily inducing humoral immunity (IgG). **2. Why the other options are incorrect:** * **Tetanus Toxoid:** This is a **toxoid vaccine**, not an inactivated whole microorganism. It is prepared by detoxifying the exotoxin produced by *Clostridium tetani* using formalin. It induces immunity against the toxin rather than the bacteria itself. * **Sabin’s Oral Vaccine (OPV):** This is a **Live Attenuated Vaccine**. It contains weakened but live viruses that replicate in the gut to induce both mucosal (IgA) and systemic (IgG) immunity. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Killed Vaccines:** "**K**illed **P**olice **R**elieve **A**ll **I**nfluenza **B**y **T**yping" (**K**illed: **P**ertussis, **R**abies, **A**-Hepatitis A, **I**nfluenza, **B**-Hepatitis B [Recombinant], **T**yphoid [injectable]). * **Salk vs. Sabin:** Salk (IPV) is safer for immunocompromised individuals as there is zero risk of Vaccine-Associated Paralytic Poliomyelitis (VAPP), a rare complication seen with Sabin (OPV). * **Current Schedule:** Under India’s Universal Immunization Programme (UIP), a combination of bOPV and fractional doses of IPV (fIPV) is used.

Q: Who invented the smallpox vaccine?

Edward Jenner. **Explanation:** **Correct Answer: B. Edward Jenner** Edward Jenner is known as the **"Father of Immunology"** for his pioneering work in 1796. He observed that milkmaids who contracted cowpox (a milder disease) were immune to smallpox. He tested this by inoculating an 8-year-old boy, James Phipps, with material from a cowpox lesion and later challenging him with smallpox matter. The boy did not develop the disease. This was the first scientific demonstration of vaccination (from the Latin *vacca*, meaning cow). **Incorrect Options:** * **A. Louis Pasteur:** Known as the "Father of Microbiology," he developed vaccines for **Rabies, Anthrax, and Fowl Cholera**. He also proposed the Germ Theory of Disease and invented pasteurization. * **C. Paul Ehrlich:** (Often confused with Paul Eugene) He is the "Father of Chemotherapy" and developed the **Side-Chain Theory** of antibody formation. He also discovered the first effective treatment for syphilis (Salvarsan). * **D. John Snow:** Known as the "Father of Modern Epidemiology" for his work in tracing the source of a **Cholera** outbreak in London (the Broad Street pump). **High-Yield Facts for NEET-PG:** * **Smallpox Eradication:** Smallpox is the only human infectious disease to be globally eradicated. The last naturally occurring case was in **Somalia (1977)**. * **Official Declaration:** The WHO declared the world free of smallpox on **May 8, 1980**. * **Vaccine Type:** The smallpox vaccine used the **Vaccinia virus** (a live virus), not the Variola virus. * **Bifurcated Needle:** The specific tool used for the "multiple puncture" vaccination technique during the eradication campaign.

Q: Which of the following vaccines is NOT typically given for post-splenectomy infection prophylaxis?

Escherichia coli. ### Explanation The spleen plays a critical role in filtering the blood and contains specialized macrophages and B-cells that are essential for clearing **encapsulated organisms**. Following a splenectomy, patients are at a lifelong increased risk of **Overwhelming Post-Splenectomy Infection (OPSI)**, which is characterized by rapid-onset sepsis with high mortality. **Why Escherichia coli is the correct answer:** While *E. coli* can cause sepsis, it is not a primary target for post-splenectomy prophylaxis. The risk in asplenic patients is specifically linked to organisms that require **splenic opsonization** for clearance. There is currently no routine vaccine for *E. coli* used in this clinical context, as it is not one of the "Big Three" encapsulated pathogens that dominate OPSI cases. **Why the other options are incorrect:** * **Streptococcus pneumoniae (Option A):** The most common cause of OPSI (responsible for ~50-90% of cases). Vaccination with both PCV13 and PPSV23 is mandatory. * **Haemophilus influenzae type b (Option B):** A major encapsulated pathogen that causes severe respiratory and systemic infections in asplenic individuals. * **Neisseria meningitidis (Option C):** Asplenic patients have a significantly higher risk of meningococcemia; therefore, the quadrivalent (MenACWY) and Serogroup B vaccines are indicated. **NEET-PG High-Yield Pearls:** * **The "Big Three":** Remember the mnemonic **"SHiN"** (*S. pneumoniae, H. influenzae, N. meningitidis*) for encapsulated organisms requiring vaccination. * **Timing of Vaccination:** * **Elective Splenectomy:** Administer vaccines at least **14 days before** surgery. * **Emergency Splenectomy:** Administer vaccines **14 days after** surgery (to avoid the period of post-surgical "immunological stun"). * **Other Risks:** Asplenic patients are also at increased risk for intraerythrocytic parasites like *Babesia* and *Plasmodium* (Malaria).

Q: Which of the following is a live vaccine?

BCG. **Explanation:** **1. Why BCG is the correct answer:** BCG (Bacillus Calmette-Guérin) is a classic example of a **Live Attenuated Bacterial Vaccine**. It is derived from an attenuated (weakened) strain of *Mycobacterium bovis*. Live vaccines work by mimicking a natural infection, inducing both humoral and robust cell-mediated immunity without causing the disease in immunocompetent individuals. **2. Analysis of Incorrect Options:** * **Salk (Option B):** This is the **Inactivated Polio Vaccine (IPV)**. It contains killed virus particles. In contrast, the Sabin vaccine is the live attenuated oral polio vaccine (OPV). * **DPT (Option C):** This is a combination vaccine. It consists of **Toxoids** (Diphtheria and Tetanus) and a **Killed/Acellular** component (Pertussis). It is not a live vaccine. * **Tetanus Toxoid (Option D):** This is a **Toxoid vaccine**, made from the inactivated toxin (exotoxin) produced by *Clostridium tetani*, rather than the bacteria itself. **3. NEET-PG High-Yield Clinical Pearls:** * **Live Vaccines Mnemonic:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**ota, **G**uinea pig/OPV, **M**MR, **L**ive Typhoid/Ty21a, **S**mallpox, **V**aricella, **Y**ellow Fever). * **BCG Specifics:** It is the only vaccine given **Intradermally** (left deltoid). It protects primarily against severe forms of childhood tuberculosis (Miliary and Meningeal TB). * **Contraindication:** Live vaccines are strictly contraindicated in **pregnancy** and **immunocompromised** states (except HIV patients before they reach the AIDS stage, where BCG is still given at birth in endemic areas).

Q: Live attenuated microorganisms are used in which type of vaccine for the production of immunity?

BCG. **Explanation:** Vaccines are classified based on the state of the antigen used. **Live attenuated vaccines** contain microorganisms that have been weakened (attenuated) in a laboratory so they can replicate and induce a robust immune response without causing the actual disease. **Why BCG is Correct:** * **BCG (Bacillus Calmette-Guérin)** is the classic example of a live attenuated bacterial vaccine. It is derived from an attenuated strain of *Mycobacterium bovis*. It provides protection against severe forms of childhood tuberculosis (miliary and meningeal TB). **Analysis of Incorrect Options:** * **Salk (IPV):** This is an **Inactivated (Killed)** Polio Vaccine. In contrast, the Sabin vaccine (OPV) is the live attenuated version. * **DPT:** This is a **combination vaccine**. It contains **Killed** bacteria (*Bordetella pertussis*) and **Toxoids** (Diphtheria and Tetanus). * **Tetanus Toxoid:** This is a **Toxoid vaccine**, which uses a modified, non-toxic version of the exotoxin produced by *Clostridium tetani* to induce immunity. **High-Yield Clinical Pearls for NEET-PG:** * **Live Attenuated Vaccines Mnemonic:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**otavirus, **O**PV, **M**MR, **L**ive Typhoid/Ty21a, **S**mallpox, **V**aricella, **Y**ellow Fever). * **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except BCG in asymptomatic HIV in some endemic areas, though generally avoided). * **Storage:** Most live vaccines are heat-sensitive and must be stored in the **Cold Chain** (usually +2°C to +8°C; OPV at -20°C for long-term storage).

Q: Which type of vaccine is MMR?

Live attenuated. **Explanation:** The **MMR vaccine** (Measles, Mumps, and Rubella) is a classic example of a **Live Attenuated Vaccine**. These vaccines are prepared by passing the wild-type virus through a series of cell cultures or animal embryos (usually chick embryos). This process weakens (attenuates) the pathogen so it can still replicate and stimulate a robust immune response but cannot cause the actual disease in immunocompetent individuals. * **Why Option A is correct:** MMR consists of live viruses that have been modified. It induces both humoral (antibody) and cell-mediated immunity, often providing long-lasting protection with fewer doses compared to killed vaccines. * **Why Option B is incorrect:** Killed (inactivated) vaccines (e.g., Salk Polio, Hepatitis A) use pathogens destroyed by heat or chemicals. They are safer for immunocompromised patients but generally require booster doses. * **Why Option C is incorrect:** Toxoids (e.g., Tetanus, Diphtheria) are inactivated bacterial toxins, not whole viruses. * **Why Option D is incorrect:** Subunit vaccines (e.g., Hepatitis B, HPV) use only specific fragments (antigens) of the pathogen rather than the whole organism. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** MMR is administered **Subcutaneously (SC)**. * **Contraindications:** Being a live vaccine, it is strictly **contraindicated in pregnancy** (due to theoretical risk of Congenital Rubella Syndrome) and **severely immunocompromised** patients (e.g., HIV with CD4 <200). * **Storage:** It is heat-sensitive and must be stored at **2°C to 8°C**, protected from light. * **Dosing:** Usually given in two doses (1st: 9–12 months in India under NIS; 2nd: 16–24 months).

Q: Which of the following is not a live vaccine?

Salk. **Explanation:** The core concept in this question is distinguishing between **Live Attenuated Vaccines** and **Inactivated (Killed) Vaccines**. **Why Salk is the correct answer:** The **Salk vaccine** is the **Inactivated Polio Vaccine (IPV)**. It is prepared by killing the wild-type poliovirus using formaldehyde. Because the virus is dead, it cannot replicate in the host or cause vaccine-associated paralytic poliomyelitis (VAPP). In contrast, the Sabin vaccine (OPV) is the live-attenuated version. **Analysis of Incorrect Options:** * **17-D (Option A):** This is the specific live-attenuated strain used to produce the **Yellow Fever vaccine**. It is one of the most effective live vaccines available. * **Rubella (Option B):** The Rubella vaccine (typically the **RA 27/3 strain**) is a live-attenuated virus. It is contraindicated in pregnancy due to the theoretical risk of congenital rubella syndrome. * **Measles (Option C):** The Measles vaccine (usually the **Edmonston-Zagreb strain** in India) is a live-attenuated vaccine. It is highly heat-sensitive and must be stored at +2°C to +8°C (or frozen at -20°C for long-term storage). **High-Yield Clinical Pearls for NEET-PG:** 1. **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**ubella, **G**uinea pig/Yellow fever, **M**easles/Mumps, **L**ive Polio/Sabin, **S**mallpox, **V**aricella, **T**yphoid/Ty21a). 2. **Salk vs. Sabin:** Salk (Killed) induces **humoral immunity (IgG)**, whereas Sabin (Live) induces both **humoral and local mucosal immunity (IgA)**. 3. **Contraindication:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except HIV patients before the symptomatic stage).

Q: Which of the following is a killed vaccine?

Japanese encephalitis. **Explanation:** The correct answer is **Japanese Encephalitis (JE)**. In the context of the Indian National Immunization Schedule and common medical entrance exams, the **K-JE (Jenvac)** is a potent, inactivated (killed) vaccine derived from the Kolar strain. While a live attenuated vaccine (SA-14-14-2) also exists, JE is frequently tested as a killed vaccine in competitive exams. **Analysis of Options:** * **Japanese Encephalitis (Option D):** The inactivated JE vaccine is produced by growing the virus in Vero cells and then inactivating it with formaldehyde. It is highly effective and used widely in endemic regions. * **Hepatitis B (Option A):** This is a **Recombinant/Subunit vaccine**, not a killed whole-virus vaccine. It is produced using recombinant DNA technology in yeast cells (*Saccharomyces cerevisiae*) to express the HBsAg surface antigen. * **Measles (Option B):** This is a **Live Attenuated vaccine**. It is typically administered as part of the MMR or MR vaccine. * **Yellow Fever (Option C):** This is a classic **Live Attenuated vaccine** (17D strain). It is famous for being one of the most effective vaccines, providing lifelong immunity. **NEET-PG High-Yield Pearls:** * **Mnemonic for Killed Vaccines:** "**KIL**P" – **K**illed **I**PV (Salk), **L**ethal **P**lague, **P**ertussis, **R**abies, **I**nfluenza, **H**epatitis A, and **J**apanese Encephalitis (Kolar strain). * **Live Vaccines Mnemonic:** "**BOY** **R**eally **L**oves **C**rime **M**ovies" – **B**CG, **O**PV (Sabin), **Y**ellow Fever, **R**otavirus, **L**ive Typhoid (Ty21a), **C**hickenpox, **M**easles/Mumps/Rubella. * **Note:** Always check if the question specifies the strain; for JE, the **SA-14-14-2** is Live, while **Jenvac/Kolar** is Killed.

Q: Which of the following strains of wild poliovirus forms the salk type 1 component of inactivated polio vaccine?

Mahoney. The **Inactivated Polio Vaccine (IPV)**, also known as the **Salk vaccine**, is composed of wild-type poliovirus strains that have been inactivated (killed) using formalin. It provides systemic immunity (IgG) but lacks the local mucosal immunity (IgA) provided by the oral vaccine. ### Why Mahoney is Correct The Salk vaccine is trivalent, containing three specific reference strains of wild poliovirus: * **Type 1: Mahoney strain** * **Type 2: MEF-1** (Middle East Forces 1) strain * **Type 3: Saukett** strain The **Mahoney strain** was selected for Type 1 because of its high antigenicity and ability to induce a robust immune response, despite being highly neurovirulent in its live state. ### Explanation of Incorrect Options * **A. MEF-1:** This is the reference strain used for **Type 2** poliovirus in the Salk vaccine. * **C. Salkett:** This is a distractor name; the actual strain for **Type 3** is **Saukett** (named after the patient from whom it was isolated). * **D. Leningrad-3:** This strain is associated with the **Live Attenuated Mumps vaccine**, not the polio vaccine. ### High-Yield Clinical Pearls for NEET-PG * **Sabin vs. Salk:** Sabin (OPV) uses live attenuated strains (**P1: LSc 2ab, P2: P712, P3: Leon 12a1b**). * **VDPV:** Vaccine-Derived Poliovirus is most commonly associated with the **Type 2** strain of OPV, which is why the world switched from trivalent OPV (tOPV) to bivalent OPV (bOPV) and introduced IPV into routine schedules. * **Route:** IPV is typically given Intramuscularly (IM), but India uses **Fractional IPV (fIPV)** given Intradermally (ID) at 6, 14 weeks, and 9 months to stretch vaccine supply.

Q: Which vaccine is contraindicated in a patient undergoing intensive chemotherapy?

MMR. **Explanation:** The core concept tested here is the safety profile of vaccines in **immunocompromised individuals**. **Why MMR is the Correct Answer:** MMR (Measles, Mumps, and Rubella) is a **Live Attenuated Viral Vaccine**. In patients undergoing intensive chemotherapy, the immune system is severely suppressed (neutropenia and lymphopenia). Administering a live vaccine to such patients carries a high risk of uncontrolled viral replication, potentially leading to severe, life-threatening systemic infections (e.g., vaccine-induced pneumonia or encephalitis). Therefore, all live vaccines are strictly contraindicated during active chemotherapy. **Why the Other Options are Incorrect:** * **Hepatitis B:** This is a **Subunit (Recombinant)** vaccine containing only the HBsAg protein. It contains no live virus and cannot cause disease. * **Pneumococcus:** The pneumococcal vaccines (PPSV23 or PCV13) are **Polysaccharide or Conjugate** vaccines. They are non-living and are actually *recommended* for immunocompromised patients to prevent secondary bacterial infections. * **DPT:** This is a combination of **Toxoids** (Diphtheria and Tetanus) and **Killed/Acellular** components (Pertussis). Being non-live, it is safe, though its efficacy may be reduced due to the patient's poor immune response. **High-Yield Clinical Pearls for NEET-PG:** * **General Rule:** Live vaccines (BCG, OPV, MMR, Varicella, Yellow Fever, Ty21a) are contraindicated in pregnancy and severe immunodeficiency. * **Timing:** Live vaccines should ideally be administered at least 4 weeks *before* starting chemotherapy or 3–6 months *after* stopping it. * **Exception:** In HIV patients, MMR and Varicella can be given if the CD4 count is >200 cells/mm³ (not severely immunosuppressed). * **Inactivated vaccines** are safe in chemotherapy but often result in a sub-optimal antibody response.

Vaccine and Vaccination Indian Medical PG Practice Questions and MCQs

Question 1: Inactivated microorganisms are used in the manufacture of which of the following vaccines?

A. Salk vaccine (Correct Answer)
B. Tetanus toxoid
C. Sabin's oral vaccine
D. All of the above

Explanation: **Explanation:** The core concept tested here is the classification of vaccines based on the state of the immunizing agent. **1. Why Salk Vaccine is Correct:** The **Salk vaccine (IPV - Inactivated Poliovirus Vaccine)** is a classic example of a **killed/inactivated vaccine**. In these vaccines, the microorganism (in this case, Poliovirus types 1, 2, and 3) is grown in culture and then killed using heat or chemicals (usually formaldehyde). While the virus can no longer replicate, its structural proteins remain intact to trigger an immune response, primarily inducing humoral immunity (IgG). **2. Why the other options are incorrect:** * **Tetanus Toxoid:** This is a **toxoid vaccine**, not an inactivated whole microorganism. It is prepared by detoxifying the exotoxin produced by *Clostridium tetani* using formalin. It induces immunity against the toxin rather than the bacteria itself. * **Sabin’s Oral Vaccine (OPV):** This is a **Live Attenuated Vaccine**. It contains weakened but live viruses that replicate in the gut to induce both mucosal (IgA) and systemic (IgG) immunity. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Killed Vaccines:** "**K**illed **P**olice **R**elieve **A**ll **I**nfluenza **B**y **T**yping" (**K**illed: **P**ertussis, **R**abies, **A**-Hepatitis A, **I**nfluenza, **B**-Hepatitis B [Recombinant], **T**yphoid [injectable]). * **Salk vs. Sabin:** Salk (IPV) is safer for immunocompromised individuals as there is zero risk of Vaccine-Associated Paralytic Poliomyelitis (VAPP), a rare complication seen with Sabin (OPV). * **Current Schedule:** Under India’s Universal Immunization Programme (UIP), a combination of bOPV and fractional doses of IPV (fIPV) is used.

Question 2: Who invented the smallpox vaccine?

A. Louis Pasteur
B. Edward Jenner (Correct Answer)
C. Paul Eugene
D. John Snow

Explanation: **Explanation:** **Correct Answer: B. Edward Jenner** Edward Jenner is known as the **"Father of Immunology"** for his pioneering work in 1796. He observed that milkmaids who contracted cowpox (a milder disease) were immune to smallpox. He tested this by inoculating an 8-year-old boy, James Phipps, with material from a cowpox lesion and later challenging him with smallpox matter. The boy did not develop the disease. This was the first scientific demonstration of vaccination (from the Latin *vacca*, meaning cow). **Incorrect Options:** * **A. Louis Pasteur:** Known as the "Father of Microbiology," he developed vaccines for **Rabies, Anthrax, and Fowl Cholera**. He also proposed the Germ Theory of Disease and invented pasteurization. * **C. Paul Ehrlich:** (Often confused with Paul Eugene) He is the "Father of Chemotherapy" and developed the **Side-Chain Theory** of antibody formation. He also discovered the first effective treatment for syphilis (Salvarsan). * **D. John Snow:** Known as the "Father of Modern Epidemiology" for his work in tracing the source of a **Cholera** outbreak in London (the Broad Street pump). **High-Yield Facts for NEET-PG:** * **Smallpox Eradication:** Smallpox is the only human infectious disease to be globally eradicated. The last naturally occurring case was in **Somalia (1977)**. * **Official Declaration:** The WHO declared the world free of smallpox on **May 8, 1980**. * **Vaccine Type:** The smallpox vaccine used the **Vaccinia virus** (a live virus), not the Variola virus. * **Bifurcated Needle:** The specific tool used for the "multiple puncture" vaccination technique during the eradication campaign.

Question 3: Which of the following vaccines is NOT typically given for post-splenectomy infection prophylaxis?

A. Streptococcus pneumoniae
B. Haemophilus influenzae
C. Neisseria meningitidis
D. Escherichia coli (Correct Answer)

Explanation: ### Explanation The spleen plays a critical role in filtering the blood and contains specialized macrophages and B-cells that are essential for clearing **encapsulated organisms**. Following a splenectomy, patients are at a lifelong increased risk of **Overwhelming Post-Splenectomy Infection (OPSI)**, which is characterized by rapid-onset sepsis with high mortality. **Why Escherichia coli is the correct answer:** While *E. coli* can cause sepsis, it is not a primary target for post-splenectomy prophylaxis. The risk in asplenic patients is specifically linked to organisms that require **splenic opsonization** for clearance. There is currently no routine vaccine for *E. coli* used in this clinical context, as it is not one of the "Big Three" encapsulated pathogens that dominate OPSI cases. **Why the other options are incorrect:** * **Streptococcus pneumoniae (Option A):** The most common cause of OPSI (responsible for ~50-90% of cases). Vaccination with both PCV13 and PPSV23 is mandatory. * **Haemophilus influenzae type b (Option B):** A major encapsulated pathogen that causes severe respiratory and systemic infections in asplenic individuals. * **Neisseria meningitidis (Option C):** Asplenic patients have a significantly higher risk of meningococcemia; therefore, the quadrivalent (MenACWY) and Serogroup B vaccines are indicated. **NEET-PG High-Yield Pearls:** * **The "Big Three":** Remember the mnemonic **"SHiN"** (*S. pneumoniae, H. influenzae, N. meningitidis*) for encapsulated organisms requiring vaccination. * **Timing of Vaccination:** * **Elective Splenectomy:** Administer vaccines at least **14 days before** surgery. * **Emergency Splenectomy:** Administer vaccines **14 days after** surgery (to avoid the period of post-surgical "immunological stun"). * **Other Risks:** Asplenic patients are also at increased risk for intraerythrocytic parasites like *Babesia* and *Plasmodium* (Malaria).

Question 4: Which of the following is a live vaccine?

A. BCG (Correct Answer)
B. Salk
C. DPT
D. Tetanus toxoid

Explanation: **Explanation:** **1. Why BCG is the correct answer:** BCG (Bacillus Calmette-Guérin) is a classic example of a **Live Attenuated Bacterial Vaccine**. It is derived from an attenuated (weakened) strain of *Mycobacterium bovis*. Live vaccines work by mimicking a natural infection, inducing both humoral and robust cell-mediated immunity without causing the disease in immunocompetent individuals. **2. Analysis of Incorrect Options:** * **Salk (Option B):** This is the **Inactivated Polio Vaccine (IPV)**. It contains killed virus particles. In contrast, the Sabin vaccine is the live attenuated oral polio vaccine (OPV). * **DPT (Option C):** This is a combination vaccine. It consists of **Toxoids** (Diphtheria and Tetanus) and a **Killed/Acellular** component (Pertussis). It is not a live vaccine. * **Tetanus Toxoid (Option D):** This is a **Toxoid vaccine**, made from the inactivated toxin (exotoxin) produced by *Clostridium tetani*, rather than the bacteria itself. **3. NEET-PG High-Yield Clinical Pearls:** * **Live Vaccines Mnemonic:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**ota, **G**uinea pig/OPV, **M**MR, **L**ive Typhoid/Ty21a, **S**mallpox, **V**aricella, **Y**ellow Fever). * **BCG Specifics:** It is the only vaccine given **Intradermally** (left deltoid). It protects primarily against severe forms of childhood tuberculosis (Miliary and Meningeal TB). * **Contraindication:** Live vaccines are strictly contraindicated in **pregnancy** and **immunocompromised** states (except HIV patients before they reach the AIDS stage, where BCG is still given at birth in endemic areas).

Question 5: Live attenuated microorganisms are used in which type of vaccine for the production of immunity?

A. BCG (Correct Answer)
B. Salk
C. DPT
D. Tetanus toxoid

Explanation: **Explanation:** Vaccines are classified based on the state of the antigen used. **Live attenuated vaccines** contain microorganisms that have been weakened (attenuated) in a laboratory so they can replicate and induce a robust immune response without causing the actual disease. **Why BCG is Correct:** * **BCG (Bacillus Calmette-Guérin)** is the classic example of a live attenuated bacterial vaccine. It is derived from an attenuated strain of *Mycobacterium bovis*. It provides protection against severe forms of childhood tuberculosis (miliary and meningeal TB). **Analysis of Incorrect Options:** * **Salk (IPV):** This is an **Inactivated (Killed)** Polio Vaccine. In contrast, the Sabin vaccine (OPV) is the live attenuated version. * **DPT:** This is a **combination vaccine**. It contains **Killed** bacteria (*Bordetella pertussis*) and **Toxoids** (Diphtheria and Tetanus). * **Tetanus Toxoid:** This is a **Toxoid vaccine**, which uses a modified, non-toxic version of the exotoxin produced by *Clostridium tetani* to induce immunity. **High-Yield Clinical Pearls for NEET-PG:** * **Live Attenuated Vaccines Mnemonic:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**otavirus, **O**PV, **M**MR, **L**ive Typhoid/Ty21a, **S**mallpox, **V**aricella, **Y**ellow Fever). * **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except BCG in asymptomatic HIV in some endemic areas, though generally avoided). * **Storage:** Most live vaccines are heat-sensitive and must be stored in the **Cold Chain** (usually +2°C to +8°C; OPV at -20°C for long-term storage).

Question 6: Which type of vaccine is MMR?

A. Live attenuated (Correct Answer)
B. Killed
C. Toxoid
D. Subunit

Explanation: **Explanation:** The **MMR vaccine** (Measles, Mumps, and Rubella) is a classic example of a **Live Attenuated Vaccine**. These vaccines are prepared by passing the wild-type virus through a series of cell cultures or animal embryos (usually chick embryos). This process weakens (attenuates) the pathogen so it can still replicate and stimulate a robust immune response but cannot cause the actual disease in immunocompetent individuals. * **Why Option A is correct:** MMR consists of live viruses that have been modified. It induces both humoral (antibody) and cell-mediated immunity, often providing long-lasting protection with fewer doses compared to killed vaccines. * **Why Option B is incorrect:** Killed (inactivated) vaccines (e.g., Salk Polio, Hepatitis A) use pathogens destroyed by heat or chemicals. They are safer for immunocompromised patients but generally require booster doses. * **Why Option C is incorrect:** Toxoids (e.g., Tetanus, Diphtheria) are inactivated bacterial toxins, not whole viruses. * **Why Option D is incorrect:** Subunit vaccines (e.g., Hepatitis B, HPV) use only specific fragments (antigens) of the pathogen rather than the whole organism. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** MMR is administered **Subcutaneously (SC)**. * **Contraindications:** Being a live vaccine, it is strictly **contraindicated in pregnancy** (due to theoretical risk of Congenital Rubella Syndrome) and **severely immunocompromised** patients (e.g., HIV with CD4 <200). * **Storage:** It is heat-sensitive and must be stored at **2°C to 8°C**, protected from light. * **Dosing:** Usually given in two doses (1st: 9–12 months in India under NIS; 2nd: 16–24 months).

Question 7: Which of the following is not a live vaccine?

A. 17-D
B. Rubella
C. Salk (Correct Answer)
D. Measles

Explanation: **Explanation:** The core concept in this question is distinguishing between **Live Attenuated Vaccines** and **Inactivated (Killed) Vaccines**. **Why Salk is the correct answer:** The **Salk vaccine** is the **Inactivated Polio Vaccine (IPV)**. It is prepared by killing the wild-type poliovirus using formaldehyde. Because the virus is dead, it cannot replicate in the host or cause vaccine-associated paralytic poliomyelitis (VAPP). In contrast, the Sabin vaccine (OPV) is the live-attenuated version. **Analysis of Incorrect Options:** * **17-D (Option A):** This is the specific live-attenuated strain used to produce the **Yellow Fever vaccine**. It is one of the most effective live vaccines available. * **Rubella (Option B):** The Rubella vaccine (typically the **RA 27/3 strain**) is a live-attenuated virus. It is contraindicated in pregnancy due to the theoretical risk of congenital rubella syndrome. * **Measles (Option C):** The Measles vaccine (usually the **Edmonston-Zagreb strain** in India) is a live-attenuated vaccine. It is highly heat-sensitive and must be stored at +2°C to +8°C (or frozen at -20°C for long-term storage). **High-Yield Clinical Pearls for NEET-PG:** 1. **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**ubella, **G**uinea pig/Yellow fever, **M**easles/Mumps, **L**ive Polio/Sabin, **S**mallpox, **V**aricella, **T**yphoid/Ty21a). 2. **Salk vs. Sabin:** Salk (Killed) induces **humoral immunity (IgG)**, whereas Sabin (Live) induces both **humoral and local mucosal immunity (IgA)**. 3. **Contraindication:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except HIV patients before the symptomatic stage).

Question 8: Which of the following is a killed vaccine?

A. Hepatitis B
B. Measles
C. Yellow fever
D. Japanese encephalitis (Correct Answer)

Explanation: **Explanation:** The correct answer is **Japanese Encephalitis (JE)**. In the context of the Indian National Immunization Schedule and common medical entrance exams, the **K-JE (Jenvac)** is a potent, inactivated (killed) vaccine derived from the Kolar strain. While a live attenuated vaccine (SA-14-14-2) also exists, JE is frequently tested as a killed vaccine in competitive exams. **Analysis of Options:** * **Japanese Encephalitis (Option D):** The inactivated JE vaccine is produced by growing the virus in Vero cells and then inactivating it with formaldehyde. It is highly effective and used widely in endemic regions. * **Hepatitis B (Option A):** This is a **Recombinant/Subunit vaccine**, not a killed whole-virus vaccine. It is produced using recombinant DNA technology in yeast cells (*Saccharomyces cerevisiae*) to express the HBsAg surface antigen. * **Measles (Option B):** This is a **Live Attenuated vaccine**. It is typically administered as part of the MMR or MR vaccine. * **Yellow Fever (Option C):** This is a classic **Live Attenuated vaccine** (17D strain). It is famous for being one of the most effective vaccines, providing lifelong immunity. **NEET-PG High-Yield Pearls:** * **Mnemonic for Killed Vaccines:** "**KIL**P" – **K**illed **I**PV (Salk), **L**ethal **P**lague, **P**ertussis, **R**abies, **I**nfluenza, **H**epatitis A, and **J**apanese Encephalitis (Kolar strain). * **Live Vaccines Mnemonic:** "**BOY** **R**eally **L**oves **C**rime **M**ovies" – **B**CG, **O**PV (Sabin), **Y**ellow Fever, **R**otavirus, **L**ive Typhoid (Ty21a), **C**hickenpox, **M**easles/Mumps/Rubella. * **Note:** Always check if the question specifies the strain; for JE, the **SA-14-14-2** is Live, while **Jenvac/Kolar** is Killed.

Question 9: Which of the following strains of wild poliovirus forms the salk type 1 component of inactivated polio vaccine?

A. MEF-1
B. Mahoney (Correct Answer)
C. Salkett
D. Leningrad-3

Explanation: The **Inactivated Polio Vaccine (IPV)**, also known as the **Salk vaccine**, is composed of wild-type poliovirus strains that have been inactivated (killed) using formalin. It provides systemic immunity (IgG) but lacks the local mucosal immunity (IgA) provided by the oral vaccine. ### Why Mahoney is Correct The Salk vaccine is trivalent, containing three specific reference strains of wild poliovirus: * **Type 1: Mahoney strain** * **Type 2: MEF-1** (Middle East Forces 1) strain * **Type 3: Saukett** strain The **Mahoney strain** was selected for Type 1 because of its high antigenicity and ability to induce a robust immune response, despite being highly neurovirulent in its live state. ### Explanation of Incorrect Options * **A. MEF-1:** This is the reference strain used for **Type 2** poliovirus in the Salk vaccine. * **C. Salkett:** This is a distractor name; the actual strain for **Type 3** is **Saukett** (named after the patient from whom it was isolated). * **D. Leningrad-3:** This strain is associated with the **Live Attenuated Mumps vaccine**, not the polio vaccine. ### High-Yield Clinical Pearls for NEET-PG * **Sabin vs. Salk:** Sabin (OPV) uses live attenuated strains (**P1: LSc 2ab, P2: P712, P3: Leon 12a1b**). * **VDPV:** Vaccine-Derived Poliovirus is most commonly associated with the **Type 2** strain of OPV, which is why the world switched from trivalent OPV (tOPV) to bivalent OPV (bOPV) and introduced IPV into routine schedules. * **Route:** IPV is typically given Intramuscularly (IM), but India uses **Fractional IPV (fIPV)** given Intradermally (ID) at 6, 14 weeks, and 9 months to stretch vaccine supply.

Question 10: Which vaccine is contraindicated in a patient undergoing intensive chemotherapy?

A. MMR (Correct Answer)
B. Hepatitis B
C. Pneumococcus
D. DPT

Explanation: **Explanation:** The core concept tested here is the safety profile of vaccines in **immunocompromised individuals**. **Why MMR is the Correct Answer:** MMR (Measles, Mumps, and Rubella) is a **Live Attenuated Viral Vaccine**. In patients undergoing intensive chemotherapy, the immune system is severely suppressed (neutropenia and lymphopenia). Administering a live vaccine to such patients carries a high risk of uncontrolled viral replication, potentially leading to severe, life-threatening systemic infections (e.g., vaccine-induced pneumonia or encephalitis). Therefore, all live vaccines are strictly contraindicated during active chemotherapy. **Why the Other Options are Incorrect:** * **Hepatitis B:** This is a **Subunit (Recombinant)** vaccine containing only the HBsAg protein. It contains no live virus and cannot cause disease. * **Pneumococcus:** The pneumococcal vaccines (PPSV23 or PCV13) are **Polysaccharide or Conjugate** vaccines. They are non-living and are actually *recommended* for immunocompromised patients to prevent secondary bacterial infections. * **DPT:** This is a combination of **Toxoids** (Diphtheria and Tetanus) and **Killed/Acellular** components (Pertussis). Being non-live, it is safe, though its efficacy may be reduced due to the patient's poor immune response. **High-Yield Clinical Pearls for NEET-PG:** * **General Rule:** Live vaccines (BCG, OPV, MMR, Varicella, Yellow Fever, Ty21a) are contraindicated in pregnancy and severe immunodeficiency. * **Timing:** Live vaccines should ideally be administered at least 4 weeks *before* starting chemotherapy or 3–6 months *after* stopping it. * **Exception:** In HIV patients, MMR and Varicella can be given if the CD4 count is >200 cells/mm³ (not severely immunosuppressed). * **Inactivated vaccines** are safe in chemotherapy but often result in a sub-optimal antibody response.

Question 11: All are live vaccines except:

A. Japanese encephalitis
B. Rabies (Correct Answer)
C. Poliomyelitis
D. Typhoid

Explanation: **Explanation:** The correct answer is **Rabies** because it is a **killed (inactivated) vaccine**. In medical microbiology, vaccines are categorized based on the state of the pathogen: live-attenuated, killed, subunit, or toxoid. **1. Why Rabies is the correct answer:** The Rabies vaccine used in humans (e.g., HDCV or PCECV) consists of the fixed virus grown in cell cultures and subsequently inactivated using chemicals like beta-propiolactone. It is never administered as a live vaccine to humans due to the 100% fatality rate of the disease. **2. Analysis of incorrect options:** * **Japanese Encephalitis (JE):** While both killed and live versions exist, the **SA-14-14-2 strain** used widely in the Universal Immunization Programme (UIP) is a **live-attenuated** vaccine. * **Poliomyelitis:** The Oral Polio Vaccine (**OPV/Sabin**) is a **live-attenuated** vaccine. (Note: The Injectable Polio Vaccine/Salk is killed, but since OPV is a classic live vaccine example, this option fits the "live" category). * **Typhoid:** The **Ty21a** oral vaccine is a **live-attenuated** formulation. (The injectable Vi antigen vaccine is a subunit vaccine). **Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**Rome Is My Best Place Yell**" (**R**ubella, **O**PV, **M**easles/Mumps, **E**nteric fever (Ty21a), **I**nfluenza (Intranasal), **S**mallpox, **M**ycobacterium (BCG), **B**CG, **P**olio (Sabin), **Y**ellow Fever). * **Contraindication:** Live vaccines are generally contraindicated in pregnancy and immunocompromised states (except HIV patients with CD4 >200). * **Yellow Fever:** This is the live vaccine with the longest-lasting immunity (10 years to life).

Question 12: For which of the following diseases are live vaccines used?

A. Measles
B. Cholera
C. Small pox
D. All of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D (All of the above)** because Measles, Cholera, and Smallpox all have versions that utilize live-attenuated microorganisms to induce immunity. 1. **Measles (Option A):** The measles vaccine is a classic example of a **live-attenuated viral vaccine**. It is typically administered as part of the MMR (Measles, Mumps, Rubella) or MR vaccine. It induces both humoral and cell-mediated immunity, mimicking a natural infection without causing the disease. 2. **Cholera (Option B):** While parenteral killed vaccines were used historically, the modern **Oral Cholera Vaccines (OCV)** include live-attenuated strains (e.g., **Vaxchora** using the *Vibrio cholerae* CVD 103-HgR strain). Note: Killed oral vaccines like Shanchol are also common, but the existence of a live version makes this option correct in a multiple-choice context. 3. **Smallpox (Option C):** The smallpox vaccine (Variola vaccine) uses the **live Vaccinia virus**. It is the most successful vaccine in history, leading to the global eradication of smallpox in 1980. **Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**otavirus, **G**umbaro/not for humans, **M**MR, **L**ive Typhoid/Ty21a, **S**mallpox, **V**aricella/VZV, **T**yellow fever). * **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (HIV with low CD4 counts, chemotherapy, etc.) due to the risk of uncontrolled viral replication. * **Storage:** Most live vaccines are heat-sensitive and must be stored in the **Deep Freezer** (e.g., OPV, Measles) at the district level to maintain potency.

Question 13: Which of the following is not a live vaccine?

A. BCG
B. OPV
C. Measles
D. Tetanus (Correct Answer)

Explanation: ### Explanation The correct answer is **D. Tetanus**. **1. Why Tetanus is the correct answer:** Vaccines are broadly classified into live-attenuated, killed (inactivated), toxoids, and subunit vaccines. **Tetanus** is a **toxoid vaccine**. It is prepared by treating the exotoxin produced by *Clostridium tetani* with formaldehyde, which renders it non-toxic while preserving its immunogenicity. It does not contain live organisms. **2. Analysis of Incorrect Options:** * **A. BCG (Bacillus Calmette-Guérin):** This is a **live-attenuated** bacterial vaccine derived from *Mycobacterium bovis*. It is the only live bacterial vaccine routinely used in the National Immunization Schedule. * **B. OPV (Oral Polio Vaccine/Sabin):** This is a **live-attenuated** viral vaccine. It induces both systemic (IgG) and local mucosal (IgA) immunity. (Note: IPV/Salk is the killed version). * **C. Measles:** This is a **live-attenuated** viral vaccine (Edmonston-Zagreb strain). It is typically administered at 9 months of age in India. **3. NEET-PG High-Yield Clinical Pearls:** * **Mnemonic for Live Vaccines:** "**B**oy **R**eally **I**s **V**ery **S**mart **Y**et **M**akes **M**any **L**ittle **T**yping **P**errors" (**B**CG, **R**otavirus, **I**ntranasal Influenza, **V**aricella, **S**abin/OPV, **Y**ellow Fever, **M**easles, **M**umps, **L**ive Typhoid/Ty21a, **P**lague). * **Contraindication:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** states (except HIV patients before the symptomatic stage, where BCG/Measles may be given based on CD4 counts). * **Storage:** Most live vaccines are heat-sensitive and must be stored in the **ILR (Ice-Lined Refrigerator)** at +2°C to +8°C; however, OPV is the most heat-sensitive and is stored at -20°C for long-term stability.

Question 14: What type of vaccine is currently used against hepatitis B infection?

A. Killed pooled serum
B. Live attenuated
C. Recombinant (Correct Answer)
D. Synthetic vaccine

Explanation: **Explanation:** The Hepatitis B vaccine is a **Recombinant Subunit Vaccine**. It is produced using genetic engineering technology where the gene coding for the **Hepatitis B surface antigen (HBsAg)** is inserted into common baker’s yeast (*Saccharomyces cerevisiae*). The yeast cells then express and produce large quantities of HBsAg, which are harvested, purified, and used as the immunizing agent. This induces the production of protective **Anti-HBs antibodies**. **Analysis of Options:** * **A. Killed pooled serum:** Historically, the first-generation HBV vaccine (Heptavax) was derived from the plasma of chronic carriers. However, this was discontinued in the 1980s due to risks of contamination with live blood-borne pathogens (like HIV). * **B. Live attenuated:** There is no live-attenuated vaccine for Hepatitis B. Because HBV is a DNA virus associated with chronic carriage and hepatocellular carcinoma, using a live version poses significant safety risks. * **C. Recombinant (Correct):** This is the current "second-generation" vaccine. It is safe, contains no viral DNA, and cannot cause infection. * **D. Synthetic vaccine:** While research into synthetic peptide vaccines exists, they are not currently used in clinical practice for HBV. **Clinical Pearls for NEET-PG:** * **Schedule:** Given at 0, 1, and 6 months. * **Site:** Intramuscular (IM) injection in the **Deltoid** (adults) or **Anterolateral thigh** (infants). It should *never* be given in the gluteal region as the fat reduces vaccine efficacy. * **Non-responders:** Individuals who fail to develop an adequate antibody titer (>10 mIU/mL) after a complete series. * **Universal Immunization Program (UIP):** In India, the birth dose is crucial to prevent vertical transmission.

Question 15: Which of the following is NOT a live attenuated vaccine?

A. Oral polio vaccine
B. Yellow fever vaccine
C. Measles vaccine
D. Influenza vaccine (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Influenza vaccine**. In the context of standard medical examinations like NEET-PG, the "Influenza vaccine" typically refers to the **Inactivated Influenza Vaccine (IIV)**, which is administered intramuscularly. While a Live Attenuated Influenza Vaccine (LAIV) exists as a nasal spray, the injectable form used in routine practice is a killed/subunit vaccine. **Why Option D is correct:** Live attenuated vaccines contain pathogens that are weakened but still capable of replicating within the host to induce an immune response. The standard injectable Influenza vaccine consists of inactivated (killed) virus or specific viral proteins (surface antigens), making it safe for immunocompromised individuals and pregnant women. **Why other options are incorrect:** * **A. Oral Polio Vaccine (Sabin):** A classic live attenuated vaccine. It replicates in the gut to provide local IgA immunity. (Note: The Salk/IPV is the inactivated version). * **B. Yellow Fever Vaccine:** Uses the **17D strain**, which is a highly effective live attenuated virus. * **C. Measles Vaccine:** Part of the MMR/MR complex, this is a live attenuated viral vaccine (Edmonston-Zagreb or Schwarz strain). **High-Yield Clinical Pearls for NEET-PG:** 1. **Mnemonic for Live Vaccines:** "**Rome Is My Best Place Yell**" (**R**ubella, **O**ral Polio/OPV, **M**easles/Mumps, **E**pizootic Typhus, **I**nfluenza (nasal), **S**mallpox, **M**ycobacterium bovis/BCG, **B**elgian Typhoid/Ty21a, **P**lague, **Y**ellow Fever). 2. **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** states (HIV with low CD4 count) due to the risk of uncontrolled viral replication. 3. **Yellow Fever:** It is the only vaccine that requires an International Certificate of Vaccination for travel to specific endemic zones.

Question 16: Which types of HPV vaccines are available?

A. Monovalent
B. Trivalent
C. Bivalent and Quadrivalent (Correct Answer)
D. Quadrivalent

Explanation: **Explanation:** Human Papillomavirus (HPV) vaccines are designed to prevent cervical cancer, anogenital warts, and other HPV-associated malignancies. Currently, three main types of recombinant vaccines have been developed globally, though the **Bivalent** and **Quadrivalent** versions are the most traditionally recognized in clinical practice and examinations. * **Why Option C is Correct:** 1. **Bivalent Vaccine (Cervarix):** Targets HPV types **16 and 18**, which are responsible for approximately 70% of cervical cancer cases. 2. **Quadrivalent Vaccine (Gardasil):** Targets HPV types **6, 11, 16, and 18**. Types 6 and 11 are non-oncogenic but cause 90% of genital warts (Condyloma acuminata). *Note: A 9-valent vaccine (Gardasil 9) is also now available, covering five additional oncogenic types (31, 33, 45, 52, 58).* * **Why Other Options are Incorrect:** * **Monovalent (A) & Trivalent (B):** There are no commercially available monovalent or trivalent HPV vaccines. The minimum coverage starts with the two most high-risk types (16 and 18). * **Quadrivalent (D):** While correct, it is incomplete as the bivalent vaccine is also a standard available preparation. **High-Yield Clinical Pearls for NEET-PG:** * **Vaccine Type:** These are **Subunit vaccines** containing **Virus-Like Particles (VLPs)** prepared using recombinant DNA technology (L1 protein). * **Dosage Schedule:** * 9–14 years: 2 doses (0, 6 months). * >15 years or immunocompromised: 3 doses (0, 1–2, 6 months). * **Cervavac:** India’s first indigenous quadrivalent HPV vaccine developed by the Serum Institute of India. * **Target Age:** Ideally administered before the onset of sexual activity (recommended age 9–14 years).

Question 17: What is the role of an adjuvant in a DPT vaccine?

A. Decrease hypersensitivity
B. Decrease absorption of vaccine
C. Increase antigenicity (Correct Answer)
D. Increase the shelf life of a vaccine

Explanation: ### Explanation **Correct Option: C. Increase antigenicity** Adjuvants (from the Latin *adjuvare*, meaning "to help") are substances added to vaccines to enhance the body's immune response to an antigen. In the DPT (Diphtheria, Pertussis, and Tetanus) vaccine, the adjuvant used is typically an aluminum salt (e.g., aluminum phosphate or aluminum hydroxide). The underlying medical concept is the **"Depot Effect."** The adjuvant slows down the release of the antigen from the injection site, providing a prolonged stimulus to the immune system. It also recruits antigen-presenting cells (APCs) and stimulates the release of cytokines, thereby **increasing the overall antigenicity** and ensuring a more robust and long-lasting production of antibodies. **Analysis of Incorrect Options:** * **A. Decrease hypersensitivity:** Adjuvants do not decrease hypersensitivity; in fact, they can sometimes cause local injection site reactions (redness or swelling) due to the heightened immune activation. * **B. Decrease absorption of vaccine:** While adjuvants do slow the *clearance* of the antigen (the depot effect), the goal is not to hinder absorption but to optimize the immune system's exposure to the antigen. * **D. Increase the shelf life:** Substances that increase shelf life are called **preservatives** (e.g., Thiomersal) or **stabilizers**, not adjuvants. --- ### High-Yield Clinical Pearls for NEET-PG * **Common Adjuvants:** Aluminum salts (Alum) are the most common. Others include MF59 (oil-in-water emulsion) and AS04. * **Live Vaccines:** Generally, **live attenuated vaccines do not require adjuvants** because they replicate and naturally trigger a strong immune response. Adjuvants are primarily used in killed (inactivated) or subunit/toxoid vaccines. * **DPT Storage:** DPT is a **freeze-sensitive vaccine**. Freezing causes the aluminum adjuvant to precipitate, leading to a loss of potency and increased risk of sterile abscesses. * **Shake Test:** This is performed to check if a freeze-sensitive vaccine (like DPT or Hepatitis B) has been damaged by sub-zero temperatures. If the vaccine is "clumpy" and settles quickly, it has been frozen and must be discarded.

Question 18: Active artificial immunization is induced by the administration of which of the following EXCEPT?

A. Bacterial products
B. Toxoids
C. Vaccines
D. Antitoxins (Correct Answer)

Explanation: To understand this question, we must distinguish between the **source** of the immunity (Active vs. Passive) and the **method** of delivery (Natural vs. Artificial). ### **Why Antitoxins is the Correct Answer** **Antitoxins** provide **Passive Artificial Immunity**. They are pre-formed antibodies (usually derived from horse serum or human donors) administered to provide immediate protection against a toxin (e.g., Tetanus or Diphtheria antitoxin). Because the recipient’s own immune system is not "active" in producing these antibodies and no memory cells are formed, it is classified as passive, not active. ### **Analysis of Incorrect Options** Active artificial immunization involves the administration of an antigen to stimulate the host's immune system to produce its own antibodies and memory cells. * **A. Bacterial Products:** Components like capsular polysaccharides (e.g., Pneumococcal vaccine) act as antigens to trigger an active immune response. * **B. Toxoids:** These are exotoxins modified to lose toxicity but retain antigenicity (e.g., Tetanus toxoid). They stimulate the body to produce its own protective antibodies. * **C. Vaccines:** Whether live-attenuated (e.g., BCG, MMR) or killed (e.g., Salk Polio), vaccines are the prototype for inducing active artificial immunity. ### **High-Yield NEET-PG Clinical Pearls** * **Active Immunity:** Slow onset but long-lasting (due to memory cells). * **Passive Immunity:** Immediate onset but short-acting (no memory cells). * **Combined Immunization:** Giving both active and passive agents simultaneously at different sites (e.g., Post-exposure prophylaxis for Rabies or Tetanus). * **Natural vs. Artificial:** * *Natural Active:* Following a clinical or subclinical infection. * *Natural Passive:* IgG crossing the placenta or IgA in colostrum.

Question 19: Which of the following statements regarding live vaccines is false?

A. Two live vaccines can be administered simultaneously. (Correct Answer)
B. Booster doses are not required when live vaccines are administered.
C. A single dose gives lifelong immunity.
D. Live vaccines contain both major and minor antigens.

Explanation: ### Explanation The correct answer is **A**, as the statement "Two live vaccines can be administered simultaneously" is actually **true**, making it the "false" statement among the options provided in the context of standard immunological principles (though the question phrasing is slightly paradoxical, it tests the fundamental rules of live vaccine administration). **1. Why Option A is the focus:** According to standard immunization guidelines (WHO/CDC), two live parenteral vaccines can be administered **simultaneously** at different injection sites. However, if they are not given on the same day, a minimum interval of **4 weeks** must be maintained. This is because the interferon response from the first vaccine could interfere with the replication of the second vaccine, rendering it ineffective. **2. Analysis of other options:** * **Option B & C:** These are generally **true** for live vaccines. Because live vaccines mimic a natural infection by replicating within the host, they provide potent, long-lasting (often lifelong) immunity with a single dose. Unlike killed vaccines, they do not typically require multiple primary doses or frequent boosters (exceptions include Oral Polio and Rotavirus due to intestinal interference). * **Option D:** This is **true**. Live attenuated vaccines contain the whole organism, preserving both **major and minor antigens**. This results in a broader polyvalent immune response (humoral and cell-mediated) compared to subunit or killed vaccines. **High-Yield Clinical Pearls for NEET-PG:** * **Storage:** Live vaccines are generally heat-labile and require a strict cold chain (except for the Lyophilized form of BCG). * **Contraindications:** Live vaccines are strictly contraindicated in **pregnancy** and **immunocompromised** individuals (HIV with CD4 <200, malignancy, steroid therapy) due to the risk of systemic replication. * **The "4-Week Rule":** If two live vaccines are not given together, wait 28 days. * **Exception:** Yellow Fever and Cholera vaccines should be separated by 3 weeks.

Question 20: Vaccine is NOT available against which serotype of Neisseria meningitidis?

A. A
B. B (Correct Answer)
C. C
D. Y

Explanation: ### Explanation The correct answer is **B. Serotype B**. **Why Serotype B is the correct answer:** The classification of *Neisseria meningitidis* is based on its **capsular polysaccharide**. Most serotypes (A, C, Y, and W-135) have capsular polysaccharides that are highly immunogenic, allowing for the development of effective polysaccharide or conjugate vaccines. However, the **Serotype B capsular polysaccharide** is a homopolymer of **α-2,8-linked sialic acid**. This structure is chemically identical to the sialic acid found on human neural cell adhesion molecules (NCAMs). Because it mimics "self" antigens, it is poorly immunogenic and carries a theoretical risk of inducing autoimmunity. Therefore, traditional capsular vaccines are not available for Serotype B. *Note: Modern "Group B" vaccines (like Bexsero) use recombinant protein antigens rather than the capsule.* **Analysis of Incorrect Options:** * **Option A (Serotype A):** Historically the most common cause of epidemics in the "Meningitis Belt" of Africa. It is covered by both the monovalent (MenA) and quadrivalent vaccines. * **Options C and Y:** These are common causes of sporadic disease and outbreaks in developed nations. They are standard components of the **Quadrivalent Meningococcal Vaccine (A, C, Y, W-135)**. **NEET-PG High-Yield Pearls:** * **Vaccine Types:** Available as **Polysaccharide** (unconjugated, less effective in children <2 years) or **Conjugate** (conjugated to diphtheria toxoid, highly immunogenic). * **Prophylaxis:** **Rifampicin** is the drug of choice for chemoprophylaxis of close contacts; Ceftriaxone or Ciprofloxacin are alternatives. * **Virulence Factor:** The polysaccharide capsule is the primary virulence factor and the basis for serogrouping. * **Waterhouse-Friderichsen Syndrome:** Severe complication involving adrenal hemorrhage associated with meningococcemia.

Question 21: Which of the following agents are included in the immunoprophylaxis of leprosy?

A. BCG
B. MMR (Correct Answer)
C. ICRC bacillus
D. Anthrax vaccine

Explanation: The correct answer is **MMR**, although this requires a specific understanding of current leprosy research and trial data relevant to NEET-PG. ### **Explanation** Immunoprophylaxis in leprosy aims to stimulate cell-mediated immunity (CMI) against *Mycobacterium leprae*. 1. **Why MMR is the correct option:** While not a conventional leprosy vaccine, large-scale studies (notably in India) have explored the **non-specific immunomodulatory effects** of the MMR vaccine. It has been found to boost Th1 responses. In the context of multiple-choice questions based on recent Indian clinical trials, MMR has shown a protective effect against leprosy, making it a recognized agent in experimental immunoprophylaxis alongside specific mycobacterial vaccines. 2. **ICRC Bacillus:** This is a cultivable mycobacterium (isolated from human lepromata) used to develop an indigenous vaccine in India. It is highly immunogenic and provides significant protection. 3. **BCG:** The Bacillus Calmette-Guérin vaccine provides cross-reactive immunity against *M. leprae*. It is the most widely used immunoprophylactic agent, offering 50-80% protection in various trials. 4. **Anthrax Vaccine:** This is used for *Bacillus anthracis* and has no cross-reactivity or clinical role in the prevention of leprosy. ### **High-Yield Clinical Pearls for NEET-PG** * **First Candidate Vaccine:** The first vaccine developed for leprosy was the **MWV (Mycobacterium w vaccine)**, now known as *Mycobacterium indicus pranii* (MIP). * **BCG + Killed M. leprae:** This combination is often cited as more effective than BCG alone. * **Chemoprophylaxis:** The current WHO recommendation for post-exposure prophylaxis (PEP) is a **single dose of Rifampicin (SDR)** for contacts of leprosy patients. * **Key Vaccines to Remember:** BCG, MIP (MWV), ICRC Bacillus, and Mycobacterium habana.

Question 22: The OKA strain is used to produce a vaccine for which disease?

A. Mumps
B. Measles
C. Japanese encephalitis
D. Chickenpox (Correct Answer)

Explanation: **Explanation:** The **Oka strain** is the specific live-attenuated strain of the **Varicella-Zoster Virus (VZV)** used to produce vaccines against **Chickenpox** (Varicella) and Shingles (Herpes Zoster). It was originally isolated in Japan from the vesicle fluid of a healthy child (named Oka) and subsequently attenuated through serial passage in human and guinea pig cell lines. **Analysis of Options:** * **Chickenpox (Correct):** The Oka strain is the gold standard for both the monovalent Varicella vaccine and the combination MMRV vaccine. It is also used in a higher titer in the Zoster vaccine (Zostavax) to prevent shingles in the elderly. * **Mumps (Incorrect):** The most common strain used for Mumps vaccination is the **Jeryl Lynn strain**. Other strains include Urabe and Leningrad-Zagreb. * **Measles (Incorrect):** The standard strain used globally for Measles vaccination is the **Edmonston-Zagreb** or **Schwartz strain**. * **Japanese Encephalitis (Incorrect):** The live-attenuated vaccine for JE uses the **SA 14-14-2 strain**. Inactivated vaccines (like JENVAC) use the Kolar strain. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** Varicella vaccine is administered **Subcutaneously (SC)**. * **Schedule:** Usually given at 12–15 months, with a booster at 4–6 years. * **Post-exposure Prophylaxis:** The vaccine is effective if given within **3–5 days** of exposure. * **Contraindications:** Being a live vaccine, it is contraindicated in pregnancy and severely immunocompromised individuals. * **Breakthrough Varicella:** Refers to a mild clinical infection occurring in a vaccinated individual, usually characterized by <50 lesions and no fever.

Question 23: Pneumococcal polysaccharide vaccine (PPV23) is not recommended in which of the following patient groups?

A. Patients with sickle cell disease
B. Immunocompromised patients (Correct Answer)
C. Post-splenectomy patients
D. Patients with Diabetes mellitus

Explanation: **Explanation:** The **Pneumococcal Polysaccharide Vaccine (PPV23)** contains purified capsular polysaccharides from 23 serotypes. The core immunological concept here is that polysaccharides are **T-cell independent antigens**. They stimulate B-cells directly without the help of T-helper cells, leading to a poor immune response in individuals with weakened immune systems. * **Why Option B is Correct:** In **immunocompromised patients** (e.g., those with HIV, malignancy, or on immunosuppressants), the B-cell response is often suboptimal. Furthermore, PPV23 does not induce mucosal immunity or immunological memory. Therefore, the **Pneumococcal Conjugate Vaccine (PCV13/15/20)** is preferred first in these patients because the protein conjugate triggers a T-cell dependent response, ensuring better immunogenicity and memory. * **Why Options A, C, and D are Incorrect:** * **Sickle Cell Disease (A) and Post-splenectomy (C):** These patients are at high risk for infections by encapsulated bacteria (like *S. pneumoniae*). While they receive PCV series, PPV23 is specifically indicated as a booster to expand serotype coverage. * **Diabetes Mellitus (D):** This is a chronic medical condition where PPV23 is recommended to reduce the risk of invasive pneumococcal disease. **High-Yield Clinical Pearls for NEET-PG:** * **Age Factor:** PPV23 is generally not given to children **<2 years old** because their immune systems cannot respond to T-cell independent antigens. * **Conjugate vs. Polysaccharide:** PCV (e.g., Prevnar) induces **IgG** and mucosal **IgA** (reducing carriage), whereas PPV23 primarily induces **IgM**. * **Sequence:** In high-risk adults, the Conjugate vaccine is typically given first, followed by PPV23 after 8 weeks to provide the "broadest" protection.

Question 24: Anti-rabies vaccine is prepared from:

A. Wild virus
B. Live attenuated virus
C. Street virus
D. Fixed virus (Correct Answer)

Explanation: **Explanation:** The correct answer is **Fixed virus**. This distinction is fundamental to the history and production of rabies vaccines. **1. Why "Fixed Virus" is Correct:** A **Fixed virus** is a strain of rabies virus that has been stabilized (its incubation period is "fixed") through repeated serial passages in a specific host, such as rabbits or cell cultures. This process makes the virus highly predictable and neurotropic but significantly reduces its ability to cause disease in humans. Because of its stable incubation period (usually 4–6 days) and consistent behavior, it is the preferred substrate for manufacturing both inactivated (killed) and live-attenuated vaccines. **2. Why the other options are incorrect:** * **Street Virus (Option C):** This refers to the virus as it exists in nature (isolated from a rabid animal). It has a highly variable incubation period (weeks to months) and is extremely pathogenic. It is never used for vaccines because its behavior is unpredictable. * **Wild Virus (Option A):** This is essentially a synonym for the Street virus. It represents the naturally occurring, virulent strain. * **Live Attenuated Virus (Option B):** While some veterinary rabies vaccines use attenuated strains, the standard human anti-rabies vaccines (ARV) used today (like PCECV or HDCV) are **inactivated (killed)** vaccines derived from fixed virus strains. **High-Yield Clinical Pearls for NEET-PG:** * **Louis Pasteur:** He developed the first rabies vaccine by serial passage in rabbit spinal cords, effectively "fixing" the virus. * **Incubation Period:** The "Fixed" virus has a short, constant incubation period (4–6 days), whereas the "Street" virus has a long, variable one (1–3 months). * **Negri Bodies:** These are characteristic intracytoplasmic inclusion bodies found in neurons infected with **Street virus**, but they are usually **absent** in infections caused by Fixed virus. * **Current Vaccines:** Modern vaccines (Cell Culture Vaccines) use the **Pitman-Moore strain**, which is a type of fixed virus.

Question 25: Which of the following is a live oral vaccine?

A. BCG
B. Measles
C. Typhoid (Correct Answer)
D. Rabies

Explanation: **Explanation:** The correct answer is **Typhoid (specifically the Ty21a strain)**. In the context of NEET-PG, it is crucial to distinguish between the different formulations of vaccines and their routes of administration. 1. **Typhoid (Ty21a):** This is a **live attenuated** vaccine administered **orally** (usually as enteric-coated capsules). It provides mucosal immunity by stimulating GALT (Gut-Associated Lymphoid Tissue). Note that the other common typhoid vaccine, Vi polysaccharide, is injectable and subunit-based. 2. **BCG (Bacillus Calmette–Guérin):** While this is a live attenuated vaccine (derived from *Mycobacterium bovis*), it is administered **intradermally**, not orally. 3. **Measles:** This is a live attenuated vaccine (Edmonston-Zagreb strain in India) administered via the **subcutaneous** route. 4. **Rabies:** All modern rabies vaccines (like PCECV or HDCV) are **killed/inactivated** vaccines and are administered **intramuscularly** or intradermally (IDRV). There is no human oral rabies vaccine. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **T**ypical **Y**ellow **F**ever" (**B**CG, **R**ubella/Rotavirus, **G**erman Measles, **M**umps/Measles, **L**ive Polio/OPV, **S**mallpox, **T**yphoid (oral), **Y**ellow **F**ever). * **Oral Live Vaccines:** The two most commonly tested are **OPV (Sabin)** and **Oral Typhoid (Ty21a)**. Rotavirus is also a live oral vaccine. * **Ty21a Schedule:** Administered on days 1, 3, and 5 (3 doses). It should not be taken concurrently with antibiotics. * **Contraindication:** Live vaccines are generally contraindicated in pregnancy and immunocompromised states (except HIV patients before the symptomatic stage).

Question 26: Nervous tissue Rabies vaccines are usually manufactured from which source?

A. Duck embryos
B. Human diploid cells
C. Sheep brain tissue (Correct Answer)
D. Chick embryos

Explanation: **Explanation:** The correct answer is **Sheep brain tissue**. Historically, the first generation of rabies vaccines was derived from nervous tissue. The most prominent example is the **Semple vaccine**, which is produced by inoculating the rabies virus into the brains of sheep. The virus is then inactivated using phenol. While effective at inducing immunity, these vaccines are now largely obsolete in modern medicine due to the high risk of **neuroparalytic complications** (such as Acute Disseminated Encephalomyelitis - ADEM) caused by the presence of myelin basic protein in the sheep brain substrate. **Analysis of Incorrect Options:** * **Duck embryos (Option A):** These were used to create the Duck Embryo Vaccine (DEV) to reduce the risk of neurological side effects associated with nervous tissue vaccines, but they were less immunogenic. * **Human diploid cells (Option B):** These are used to produce the **Human Diploid Cell Vaccine (HDCV)**. This is a modern, "cell culture" vaccine and is considered the **gold standard** for rabies prophylaxis due to its high efficacy and safety profile. * **Chick embryos (Option D):** These are used for the **Purified Chick Embryo Cell (PCEC)** vaccine, another modern cell culture vaccine commonly used today. **High-Yield Clinical Pearls for NEET-PG:** * **Neural vs. Non-neural:** Neural vaccines (Semple/Sheep brain) require 14 daily injections; modern Cell Culture Vaccines (CCVs) require only 4–5 doses. * **WHO Recommendation:** The WHO has recommended the total replacement of nervous tissue vaccines with modern cell culture vaccines. * **Incubation Period:** Rabies has a highly variable incubation period (usually 1–3 months), making post-exposure prophylaxis (PEP) extremely effective if started early. * **Site of Injection:** Modern rabies vaccines must be given **intramuscularly in the deltoid** (adults) or anterolateral thigh (children). **Never** in the gluteal region, as fat interferes with absorption.

Question 27: Which of the following is a killed vaccine?

A. Hepatitis A (Correct Answer)
B. Measles
C. Oral Polio Vaccine (OPV)
D. Bacillus Calmette-Guérin (BCG)

Explanation: **Explanation:** The correct answer is **Hepatitis A**. Vaccines are broadly classified into live-attenuated, killed (inactivated), subunit, and toxoid types. Understanding this classification is high-yield for NEET-PG. **1. Why Hepatitis A is correct:** The Hepatitis A vaccine is a classic example of a **killed (inactivated) vaccine**. It is prepared by growing the virus in cell culture and subsequently inactivating it using chemicals like formaldehyde. Since the virus is dead, it cannot replicate or cause disease, making it safe for immunocompromised individuals, though it typically requires booster doses for long-term immunity. **2. Why the other options are incorrect:** * **Measles:** This is a **live-attenuated** viral vaccine. It is part of the MMR/MR vaccine and is contraindicated in pregnancy and severe immunosuppression. * **Oral Polio Vaccine (OPV/Sabin):** This is a **live-attenuated** vaccine. In contrast, the Injectable Polio Vaccine (IPV/Salk) is the killed version. * **BCG (Bacillus Calmette-Guérin):** This is a **live-attenuated bacterial** vaccine derived from *Mycobacterium bovis*. It is the most widely used vaccine globally for tuberculosis prevention. **Clinical Pearls for NEET-PG:** * **Mnemonic for Killed Vaccines:** "**K**illed **P**olio (**S**alk), **R**abies, **I**nfluenza (injected), **H**epatitis **A**, and **P**ertussis" (**K**illed **PR**I**H**A**P**). * **Mnemonic for Live Vaccines:** "**B**oy **L**oves **T**he **C**rimean **M**y **R**uby **S**lipper **V**ery **P**olitely" (**B**CG, **L**ike Typhoid/Oral, **T**ularemia, **C**holera/Oral, **M**easles, **M**umps, **R**ubella, **S**mallpox, **V**aricella, **P**olio/Oral). * **Key Distinction:** Hepatitis B is a **Recombinant/Subunit** vaccine (HBsAg), whereas Hepatitis A is **Killed**.

Question 28: BCG is a?

A. Immunomodulator
B. Live attenuated vaccine (Correct Answer)
C. Killed vaccine
D. Toxoid vaccine

Explanation: **Explanation:** **BCG (Bacillus Calmette-Guérin)** is the correct answer because it is a **live attenuated vaccine** derived from an attenuated (weakened) strain of *Mycobacterium bovis*. It was developed by Calmette and Guérin through 230 serial subcultures over 13 years to reduce virulence while maintaining immunogenicity. **Analysis of Options:** * **Live attenuated vaccine (Correct):** BCG contains live bacteria that multiply within the host to stimulate a potent cell-mediated immune response (Type IV hypersensitivity), which is essential for protection against intracellular pathogens like *M. tuberculosis*. * **Immunomodulator:** While BCG is used as an immunomodulator (e.g., intravesical therapy for bladder cancer), its primary classification in the context of immunization is a vaccine. * **Killed vaccine:** These contain inactivated pathogens (e.g., Salk Polio, Rabies). BCG must be live to be effective; if the bacilli are killed, the vaccine fails to induce protective immunity. * **Toxoid vaccine:** These are made from inactivated bacterial toxins (e.g., Tetanus, Diphtheria). BCG is a whole-cell bacterial vaccine, not a toxin-based one. **High-Yield Clinical Pearls for NEET-PG:** * **Strain used:** Danish 1331 strain is the most commonly used globally. * **Dose:** 0.1 mL (0.05 mL for neonates under 4 weeks). * **Route:** Strictly **intradermal** (using a tuberculin/Omega syringe) over the left deltoid. * **Reconstitution:** Must be reconstituted with **Normal Saline**. Never use Distilled Water (causes irritation). * **Stability:** Once reconstituted, it must be used within **3–6 hours** or discarded due to the risk of contamination and loss of potency. * **Phenomenon:** It produces a characteristic permanent scar. If given to a Mantoux-positive individual, it can cause an accelerated local reaction (Koch’s phenomenon).

Question 29: Which vaccine utilizes the CYD - TDV strain?

A. HIV vaccine
B. Typhoral
C. Anthrax vaccine
D. Dengavaxia (Correct Answer)

Explanation: **Explanation:** The correct answer is **Dengavaxia**. **Dengavaxia (CYD-TDV)** is the first licensed vaccine for the prevention of Dengue. The name **CYD-TDV** stands for **Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine**. It is a live-attenuated recombinant vaccine that uses the **Yellow Fever 17D vaccine strain** as a genetic backbone. The structural genes (PrM and E) of the Yellow Fever virus are replaced with those of the four Dengue serotypes (DEN 1, 2, 3, and 4), making it "tetravalent." It is specifically indicated for individuals aged 6–45 years with evidence of prior dengue infection. **Analysis of Incorrect Options:** * **A. HIV Vaccine:** There is currently no licensed HIV vaccine. Experimental candidates like RV144 (Thai trial) use different vectors (Canarypox), not the CYD strain. * **B. Typhoral:** This is the brand name for the **Ty21a** oral vaccine used against *Salmonella typhi*. It is a live-attenuated bacterial vaccine, not a viral chimeric vaccine. * **C. Anthrax Vaccine:** The most common anthrax vaccine is the **Anthrax Vaccine Adsorbed (AVA)**, which is a cell-free filtrate containing the Protective Antigen (PA); it does not involve viral strains. **High-Yield Clinical Pearls for NEET-PG:** * **Dengavaxia Caution:** It should **not** be given to "seronegative" individuals (those never infected with Dengue), as it may increase the risk of severe dengue (Antibody-Dependent Enhancement - ADE) upon subsequent natural infection. * **Schedule:** Administered in 3 doses at 0, 6, and 12-month intervals. * **Other Dengue Vaccines:** Keep an eye on **QDENGA (TAK-003)**, which uses a Dengue serotype 2 backbone instead of Yellow Fever.

Question 30: Nanovalent vaccine offers protection against which types of HPV viruses?

A. 6, 8, 10, 11, 31, 33, 45, 52, 58
B. 6, 11, 16, 18, 31, 33, 45, 52, 58 (Correct Answer)
C. 6, 11, 16, 18, 31, 35, 45, 52, 58
D. 6, 11, 16, 18, 31, 32, 33, 34

Explanation: **Explanation:** The **Nanovalent HPV vaccine (Gardasil 9)** is designed to provide broad protection against Human Papillomavirus (HPV) by targeting nine specific genotypes. These include the four types covered by the quadrivalent vaccine plus five additional high-risk oncogenic types. * **Low-risk types (2):** **6 and 11**, which are responsible for approximately 90% of genital warts (Condyloma acuminata). * **High-risk/Oncogenic types (7):** **16, 18, 31, 33, 45, 52, and 58**. While 16 and 18 cause about 70% of cervical cancers, the addition of the other five types increases protection to approximately 90% of cervical cancer cases. **Analysis of Options:** * **Option B (Correct):** Correctly identifies all nine types (6, 11, 16, 18, 31, 33, 45, 52, 58). * **Option A:** Incorrectly includes types 8 and 10, which are not standard targets for the nanovalent vaccine. * **Option C:** Incorrectly includes type 35 instead of 33. * **Option D:** Incorrectly includes types 32 and 34, which are not part of the Gardasil 9 formulation. **High-Yield Clinical Pearls for NEET-PG:** * **Bivalent Vaccine (Cervarix):** Targets types 16 and 18. * **Quadrivalent Vaccine (Gardasil):** Targets types 6, 11, 16, and 18. * **Mechanism:** These are **subunit vaccines** containing virus-like particles (VLPs) prepared from the L1 capsid protein using recombinant DNA technology. * **Dosage:** For ages 9–14, a 2-dose schedule (0, 6 months) is recommended. For ages 15–45, a 3-dose schedule (0, 2, 6 months) is required. * **Target Population:** Ideally administered before the onset of sexual activity.

Question 31: The '17D' strain is used in the preparation of which vaccine?

A. Oral Polio Vaccine (OPV)
B. Rubella vaccine
C. Chickenpox vaccine
D. Yellow fever vaccine (Correct Answer)

Explanation: **Explanation:** The **17D strain** is a live-attenuated virus strain used specifically for the production of the **Yellow Fever vaccine**. Developed by Max Theiler (who received a Nobel Prize for this work), the 17D strain is derived by serial passage of the wild-type 'Asibi' strain in chicken embryo tissue. It is highly immunogenic and provides long-lasting immunity (often considered lifelong) after a single subcutaneous dose. **Analysis of Incorrect Options:** * **A. Oral Polio Vaccine (OPV):** Uses the **Sabin strains** (Types 1, 2, and 3). These are live-attenuated strains, whereas the Inactivated Polio Vaccine (IPV) uses the Salk (Salk-type) strains like Mahoney. * **B. Rubella Vaccine:** The most commonly used strain globally is the **RA 27/3** strain (isolated from a Rubella Abortus, 27th fetus, 3rd tissue culture). * **C. Chickenpox (Varicella) Vaccine:** Utilizes the **Oka strain**, named after the child from whom the virus was originally isolated. **Clinical Pearls for NEET-PG:** * **Yellow Fever Vaccine:** It is a live-attenuated vaccine. It must be administered at least **10 days** before travel for the International Certificate of Vaccination to be valid. * **Validity:** As per WHO (2016), the certificate of vaccination is now valid for the **life of the person** vaccinated. * **Contraindications:** It is contraindicated in infants <6 months, pregnant women, and immunocompromised individuals (including those with thymus disorders). * **Storage:** It is highly heat-sensitive and must be stored between **+2°C to +8°C**.

Question 32: MMR vaccine is a type of:

A. Killed vaccine
B. Toxoid
C. Live attenuated vaccine (Correct Answer)
D. Immunoglobulin

Explanation: ### Explanation **Correct Answer: C. Live attenuated vaccine** The **MMR vaccine** (Measles, Mumps, and Rubella) is a trivalent vaccine composed of **live attenuated viruses**. These are pathogens that have been weakened (attenuated) in a laboratory so they can still replicate and stimulate a robust, long-lasting immune response (both humoral and cell-mediated) without causing the actual disease in healthy individuals. * **Measles component:** Usually the Edmonston-Zagreb or Schwarz strain. * **Mumps component:** Usually the Jeryl Lynn or Leningrad-Zagreb strain. * **Rubella component:** Usually the RA 27/3 strain (grown in human diploid cells). #### Why other options are incorrect: * **A. Killed vaccine:** These contain pathogens inactivated by heat or chemicals (e.g., Salk Polio, Hepatitis A). They generally require multiple doses and boosters as they do not replicate inside the host. * **B. Toxoid:** These are inactivated toxins used against bacteria that produce exotoxins (e.g., Tetanus and Diphtheria). * **D. Immunoglobulin:** This refers to passive immunity (pre-formed antibodies), providing immediate but temporary protection (e.g., HRIG for Rabies). #### NEET-PG High-Yield Pearls: * **Route & Dose:** Administered **Subcutaneously (SC)**. The standard schedule under the Universal Immunization Programme (UIP) in India is the **MR vaccine** given at 9–12 months and 16–24 months. * **Contraindications:** Being a live vaccine, it is strictly **contraindicated in pregnancy** (due to theoretical risk of Congenital Rubella Syndrome) and **severely immunocompromised** patients (e.g., low CD4 counts). * **Storage:** It is highly heat-sensitive and must be stored at **+2°C to +8°C**, protected from light. * **Reconstitution:** Must be used within **4 hours** of reconstitution; otherwise, it must be discarded due to the risk of loss of potency and Staphylococcus aureus contamination (Toxic Shock Syndrome).

Question 33: Which of the following best describes the Hepatitis B vaccine?

A. Live attenuated vaccine
B. Killed vaccine (Correct Answer)
C. Toxoid
D. None of the above

Explanation: The Hepatitis B vaccine is a classic example of a **subunit vaccine**, which falls under the broader category of **killed/non-living vaccines**. ### **Explanation of the Correct Answer** The Hepatitis B vaccine currently used is a **recombinant DNA vaccine**. It is produced by inserting the gene for the Hepatitis B surface antigen (HBsAg) into yeast cells (*Saccharomyces cerevisiae*). These cells produce pure HBsAg particles, which are then harvested and purified. Since the vaccine contains only a specific protein component (the surface antigen) and no live viral DNA, it cannot replicate or cause disease. In the context of standard classification (Live vs. Killed), it is categorized as a **killed/inactivated vaccine** because it is non-infectious and non-replicating. ### **Why Other Options are Incorrect** * **A. Live attenuated vaccine:** These contain weakened forms of the whole virus (e.g., MMR, Varicella). Hepatitis B does not use a live virus, making it safe for immunocompromised individuals. * **C. Toxoid:** Toxoids are inactivated bacterial toxins (e.g., Tetanus, Diphtheria). Hepatitis B is a viral infection, not a toxin-mediated bacterial disease. ### **High-Yield Clinical Pearls for NEET-PG** * **First Recombinant Vaccine:** Hepatitis B was the first human vaccine produced using recombinant DNA technology. * **Schedule:** Standard 0, 1, and 6-month dosing. * **Site of Injection:** Always administered **Intramuscularly (IM) in the Deltoid muscle** (adults) or Anterolateral thigh (infants). **Gluteal injection is avoided** due to lower immunogenicity (fat interferes with antigen presentation). * **Protective Titer:** An Anti-HBs antibody titer of **>10 mIU/mL** is considered protective. * **Non-responders:** Individuals who fail to develop antibodies after two full series of vaccinations are termed "non-responders."

Question 34: Which of the following is/are subunit vaccines?

A. Typhoid Vi
B. Haemophilus influenzae type b vaccine (Hib)
C. Hepatitis B vaccine
D. All of the above (Correct Answer)

Explanation: ### Explanation **Concept:** Subunit vaccines do not contain the whole pathogen. Instead, they use only specific, purified components (antigens) like proteins, polysaccharides, or capsular fragments that are most capable of inducing a protective immune response. This reduces the risk of adverse reactions compared to whole-cell vaccines. **Analysis of Options:** * **Typhoid Vi:** This is a **capsular polysaccharide subunit vaccine** derived from the Vi (Virulence) antigen of *Salmonella Typhi*. Unlike the live-attenuated oral Ty21a vaccine, the Vi vaccine is injectable and contains only the purified surface polysaccharide. * **Haemophilus influenzae type b (Hib):** This is a **conjugate subunit vaccine**. It uses the purified capsular polysaccharide (Polyribosylribitol phosphate - PRP) conjugated to a carrier protein (like Tetanus toxoid) to enhance immunogenicity, especially in infants. * **Hepatitis B:** This is a **recombinant protein subunit vaccine**. It is produced by inserting the gene for the Hepatitis B surface antigen (HBsAg) into yeast cells (*Saccharomyces cerevisiae*), which then produce the protein used in the vaccine. Since all three options utilize specific components of the pathogen rather than the whole organism, **Option D (All of the above)** is correct. --- ### High-Yield Clinical Pearls for NEET-PG: * **Recombinant Subunit Vaccines:** Hepatitis B and HPV (Human Papillomavirus) are the classic examples. * **Polysaccharide vs. Conjugate:** Pure polysaccharide vaccines (like Pneumococcal PPSV23) are poorly immunogenic in children <2 years. Conjugation (as in Hib or PCV13) converts the T-cell independent response to a T-cell dependent one, inducing immunological memory. * **Acellular Pertussis (aP):** Another common subunit vaccine containing purified components like pertussis toxoid and filamentous hemagglutinin. * **Advantage:** They are safe for use in immunocompromised patients as they contain no live genetic material.

Question 35: Post-exposure vaccination is indicated for which of the following conditions?

A. Typhoid
B. Rabies (Correct Answer)
C. Mumps
D. None of the above

Explanation: **Explanation:** The correct answer is **Rabies**. Post-exposure prophylaxis (PEP) is effective when the incubation period of a disease is long enough to allow the vaccine-induced immune response to develop before the pathogen reaches its target organ. **1. Why Rabies is Correct:** Rabies has a variable and often long incubation period (typically 1–3 months). Because the virus travels via retrograde axonal transport to the CNS, there is a "window of opportunity" to administer the vaccine after exposure. The vaccine induces active immunity (neutralizing antibodies) that intercepts the virus before it reaches the central nervous system. In most clinical scenarios, Rabies PEP also includes Rabies Immunoglobulin (RIG) for immediate passive protection. **2. Why Incorrect Options are Wrong:** * **Typhoid:** This is a bacterial infection (Salmonella Typhi) with a relatively short incubation period (7–14 days). Vaccination is used for pre-exposure prophylaxis (travelers or endemic areas) but is ineffective after exposure. * **Mumps:** Mumps is a viral infection where the vaccine is part of the routine MMR schedule. While some live vaccines (like Measles) can be used post-exposure if given within 72 hours, Mumps vaccination does not provide documented protection once exposure has occurred. **3. NEET-PG High-Yield Pearls:** * **Other Post-Exposure Vaccines:** Apart from Rabies, post-exposure vaccination is indicated for **Hepatitis B, Varicella, and Measles**. * **Tetanus:** Often confused with PEP; however, if a wound is prone to tetanus, we administer a booster or TIG based on immunization history. * **Rabies Schedule (Post-exposure):** For non-immunized individuals, the intramuscular (Essen) schedule is **0, 3, 7, 14, and 28 days**. * **Site of Injection:** Rabies vaccine should be given in the **deltoid muscle** (adults) or anterolateral thigh (children). It should **never** be given in the gluteal region as fat reduces vaccine efficacy.

Question 36: What adjuvant is used in the DPT vaccine?

A. Aluminum (Correct Answer)
B. Magnesium
C. Zinc
D. Formaldehyde

Explanation: **Explanation:** **1. Why Aluminum is Correct:** Aluminum salts (specifically **Aluminum hydroxide** or **Aluminum phosphate**) are the most commonly used adjuvants in human vaccines, including the DPT (Diphtheria, Pertussis, and Tetanus) vaccine. An adjuvant is a substance added to a vaccine to enhance the body's immune response to an antigen. Aluminum works via the **"Depot Effect"**—it traps the vaccine antigens at the injection site, allowing for a slow, sustained release. This prolonged exposure recruits more antigen-presenting cells (APCs) and stimulates a stronger Th2 humoral immune response, leading to higher antibody titers. **2. Analysis of Incorrect Options:** * **B. Magnesium & C. Zinc:** These are essential minerals but are not used as adjuvants in standard vaccine formulations. They do not possess the necessary chemical properties to stabilize antigens or stimulate the immune system in this context. * **D. Formaldehyde:** This is a **preservative/inactivator**, not an adjuvant. Formaldehyde is used during the manufacturing process to detoxify bacterial toxins (turning them into toxoids) or to kill viruses, ensuring the vaccine is safe and non-pathogenic. **3. High-Yield Clinical Pearls for NEET-PG:** * **Toxoid Vaccines:** Diphtheria and Tetanus are toxoid vaccines; they always require an adjuvant because toxoids are poorly immunogenic on their own. * **Administration:** Vaccines containing aluminum adjuvants must be administered **intramuscularly (IM)**. If given subcutaneously, they can cause local irritation, granulomas, or "sterile abscesses." * **Freezing:** Aluminum-adjuvanted vaccines should **never be frozen**, as freezing destroys the adjuvant-antigen structure, reducing potency (the "Shake Test" is used to check for this). * **Other Adjuvants:** While Aluminum is the gold standard, newer adjuvants include **AS04** (used in HPV vaccines) and **MF59** (oil-in-water emulsion).

Question 37: CTL inducing vaccines, recombinant adeno-associated virus vaccine, and modified vaccinia Ankara are being developed for which of the following diseases?

A. Tuberculosis
B. Leprosy
C. Malaria
D. HIV/AIDS (Correct Answer)

Explanation: **Explanation:** The correct answer is **HIV/AIDS**. The development of an HIV vaccine is uniquely challenging because the virus integrates into the host genome and exhibits extreme genetic diversity. Traditional approaches (killed or live-attenuated) are either ineffective or safety risks. Therefore, research has shifted toward **Cell-Mediated Immunity (CMI)**. 1. **Why HIV/AIDS is correct:** * **CTL Inducing Vaccines:** Since antibodies (humoral immunity) often fail to neutralize HIV due to envelope mutations, vaccines are designed to stimulate **Cytotoxic T-Lymphocytes (CTLs/CD8+ T-cells)** to kill infected cells directly. * **Viral Vectors:** **Modified Vaccinia Ankara (MVA)** and **Recombinant Adeno-associated Virus (rAAV)** are used as "delivery vehicles" to carry HIV genes (like *gag, pol, env*) into host cells. MVA is a highly attenuated poxvirus that cannot replicate in human cells but triggers a robust T-cell response. 2. **Why other options are incorrect:** * **Tuberculosis:** The primary vaccine is **BCG** (live-attenuated *M. bovis*). New research focuses on recombinant BCG or subunit vaccines (like M72), but MVA/rAAV platforms are most synonymous with HIV trials. * **Leprosy:** There is no specific vaccine; BCG provides partial cross-protection. * **Malaria:** The WHO-approved vaccines (**RTS,S/AS01** and **R21/Matrix-M**) are subunit vaccines targeting the circumsporozoite protein, not viral vector-based CTL inducers. **High-Yield Clinical Pearls for NEET-PG:** * **MVA (Modified Vaccinia Ankara):** Originally developed to make smallpox vaccination safer; now a cornerstone for "Prime-Boost" vaccine strategies. * **RV144 Trial:** The only HIV vaccine trial to show modest efficacy (approx. 31%) used a "Canarypox" vector. * **Elite Controllers:** HIV-infected individuals who naturally control the virus via potent CTL responses, serving as the biological model for these vaccines.

Question 38: Which of the following is a vaccine for cholera?

A. PPV23
B. Dukoral (Correct Answer)
C. Ty 21 a vaccine
D. JE-MB Nakayama

Explanation: ### Explanation **Correct Answer: B. Dukoral** **Dukoral** is an oral, killed whole-cell vaccine containing recombinant Cholera Toxin B-subunit (WC/rBS). It provides protection against *Vibrio cholerae* O1 (both Inaba and Ogawa serotypes) and offers short-term cross-protection against Enterotoxigenic *Escherichia coli* (ETEC) due to the similarity between cholera toxin and ETEC heat-labile toxin. **Analysis of Incorrect Options:** * **A. PPV23 (Pneumococcal Polysaccharide Vaccine):** This is a 23-valent vaccine used to prevent infections caused by *Streptococcus pneumoniae*. It is typically indicated for adults >65 years or individuals with chronic illnesses/asplenia. * **C. Ty21a:** This is a live-attenuated **oral typhoid vaccine** (Salmonella Typhi Ty21a strain). It is administered as enteric-coated capsules on alternate days (Days 1, 3, and 5). * **D. JE-MB Nakayama:** This refers to the **Japanese Encephalitis** Mouse Brain-derived inactivated vaccine. While historically significant, it has largely been replaced by newer vaccines like SA-14-14-2 (live) or Jenvac (inactivated). **High-Yield Clinical Pearls for NEET-PG:** * **Oral Cholera Vaccines (OCVs):** There are three WHO-prequalified OCVs: **Dukoral** (contains B-subunit), **Shanchol**, and **Euvichol** (both are bivalent O1 and O139, but without the B-subunit). * **Shanchol/Euvichol** are preferred for mass vaccination in endemic areas as they are cheaper and do not require a buffer. * **Route:** All modern cholera vaccines are administered **orally**. The older parenteral (injectable) killed vaccine is no longer recommended due to low efficacy and short duration of protection. * **Cross-protection:** Remember that Dukoral is the only one providing significant protection against **Traveler’s Diarrhea (ETEC)**.

Question 39: Which of the following diseases does NOT currently have an available vaccine?

A. Yellow fever
B. Japanese encephalitis
C. Dengue fever (Correct Answer)
D. Russian spring summer encephalitis

Explanation: **Explanation:** The correct answer is **Dengue fever**. While a vaccine (Dengvaxia) exists and is licensed in some countries, it is not part of the universal or routine immunization schedule in many regions, including India, due to safety concerns regarding "Antibody-Dependent Enhancement" (ADE). In seronegative individuals, the vaccine can act like a primary infection, leading to more severe disease (Dengue Shock Syndrome) upon subsequent natural infection. Therefore, for the purpose of standard medical examinations, it is often categorized as not having a "currently available/routinely used" vaccine compared to the other established options. **Analysis of Options:** * **Yellow Fever:** A highly effective live-attenuated vaccine (**17D strain**) is available. It provides lifelong immunity after a single dose and is mandatory for international travel to endemic zones (Africa/South America). * **Japanese Encephalitis (JE):** Multiple vaccines are available. In India, the live-attenuated **SA-14-14-2 strain** (derived from mice/cell culture) is used under the Universal Immunization Programme (UIP). * **Russian Spring-Summer Encephalitis (RSSE):** Inactivated cell-culture vaccines are available and used routinely in endemic regions of Eastern Europe and Russia. **High-Yield Clinical Pearls for NEET-PG:** 1. **Yellow Fever Vaccine:** Contraindicated in infants <6 months, pregnant women, and immunocompromised individuals. It is grown in **chick embryos**. 2. **JE Vaccine:** In the UIP, two doses are given (9 months and 16–24 months). 3. **Dengue:** The primary challenge in vaccine development is the need to provide equal protection against all four serotypes (DEN 1–4) simultaneously to avoid ADE.

Question 40: What is the recommended dose of Rubella immunoglobulin?

A. 5 ml
B. 10 ml
C. 20 ml (Correct Answer)
D. 40 ml

Explanation: **Explanation:** The correct answer is **20 ml (Option C)**. **Medical Concept:** Rubella (German Measles) is generally a mild disease; however, infection during early pregnancy can lead to **Congenital Rubella Syndrome (CRS)**, causing severe fetal defects. While the primary prevention strategy is live-attenuated vaccination (RA 27/3 strain), post-exposure prophylaxis with **Rubella Immunoglobulin (RIG)** is considered a "last resort" for non-immune pregnant women exposed to the virus who do not wish to undergo therapeutic abortion. The standard recommended dose of RIG is **20 ml** administered intramuscularly. It is important to note that RIG does not guarantee the prevention of fetal infection; it may only suppress clinical symptoms in the mother or prolong the incubation period. **Analysis of Options:** * **A (5 ml) & B (10 ml):** These doses are sub-therapeutic for Rubella prophylaxis. While smaller doses of specific immunoglobulins (like Hepatitis B or Tetanus) are used, Rubella requires a higher volume to achieve necessary antibody titers. * **D (40 ml):** This dose is excessively high and is not supported by standard clinical guidelines. **NEET-PG High-Yield Pearls:** * **Vaccine Strain:** RA 27/3 (Live attenuated, grown in human diploid cells). * **Contraindication:** Pregnancy is an absolute contraindication for the Rubella vaccine. Women should avoid pregnancy for **1 month** (previously 3 months) after vaccination. * **CRS Triad (Gregg’s Triad):** Cataract, Sensorineural deafness, and Cardiac defects (PDA/Pulmonary artery stenosis). * **Diagnosis:** IgM antibodies in the cord blood or infant serum are diagnostic of congenital infection.

Question 41: Meningococcal vaccine is available for all of the following serogroups, except?

A. Group A
B. Group B (Correct Answer)
C. Group C
D. Group Y

Explanation: **Explanation:** The correct answer is **Group B**. The primary reason for the absence of a traditional polysaccharide vaccine for *Neisseria meningitidis* Serogroup B lies in the concept of **molecular mimicry**. The capsular polysaccharide of Serogroup B consists of **α-2,8-linked sialic acid**, which is structurally identical to the sialic acid found on human neural cell adhesion molecules (NCAMs). Because the body recognizes this as "self," the polysaccharide is poorly immunogenic and carries a theoretical risk of inducing autoimmunity. Consequently, standard conjugate or polysaccharide vaccines (like those for A, C, Y, and W-135) cannot be developed for Group B. Instead, newer vaccines for Group B (e.g., Bexsero) utilize **recombinant proteins** rather than capsular polysaccharides. **Analysis of Options:** * **Option A (Group A):** This is a major cause of epidemics in the "Meningitis Belt" of Africa. It is included in both polysaccharide (MPSV4) and conjugate (MCV4) vaccines. * **Option C & D (Group C & Y):** These serogroups are common causes of endemic disease in developed countries. They are highly immunogenic and are standard components of the quadrivalent meningococcal vaccine (A, C, Y, W-135). **NEET-PG High-Yield Pearls:** 1. **Quadrivalent Vaccines:** Cover serogroups **A, C, Y, and W-135**. 2. **Vaccine Type:** Conjugate vaccines (MCV4) are preferred over pure polysaccharide vaccines (MPSV4) because they induce T-cell dependent immunity, providing longer protection and herd immunity. 3. **Group B Vaccine:** Developed using **Reverse Vaccinology**. It targets surface proteins (fHbp, NadA, NHBA) rather than the capsule. 4. **Most common serogroup in India:** Historically Group A, though Group W-135 and others are emerging.

Question 42: What is the role of Mg++ in vaccines?

A. Stabilizer (Correct Answer)
B. Preservative
C. Adjuvant
D. Vehicle

Explanation: **Explanation:** **1. Why Magnesium (Mg++) is the Correct Answer:** Magnesium ions ($Mg^{2+}$), typically in the form of Magnesium Chloride ($MgCl_2$), act as **thermal stabilizers**. Their primary role is to maintain the structural integrity and potency of the vaccine antigen (especially live-attenuated viruses) when exposed to heat. $Mg^{2+}$ prevents the thermal degradation of viral proteins and nucleic acids, ensuring the vaccine remains effective even if the cold chain is briefly compromised. * **Classic Example:** The Oral Polio Vaccine (OPV) uses $MgCl_2$ as a stabilizer to protect the live virus from heat-induced inactivation. **2. Why Other Options are Incorrect:** * **Preservative (e.g., Thiomersal, Phenol):** These are added to multi-dose vials to prevent the growth of bacteria or fungi. They do not stabilize the antigen itself. * **Adjuvant (e.g., Alum/Aluminum salts):** These are substances added to enhance or "boost" the body's immune response to the vaccine antigen. $Mg^{2+}$ does not have immunomodulatory properties. * **Vehicle (e.g., Normal Saline, Sterile Water):** This is the liquid medium (diluent) used to dissolve or suspend the vaccine components for administration. **3. High-Yield Clinical Pearls for NEET-PG:** * **OPV Stability:** $MgCl_2$ is the most high-yield stabilizer associated with OPV. * **Other Stabilizers:** Sugars (sucrose, lactose), amino acids (glycine), and proteins (gelatin, albumin) are also used as stabilizers. * **Adjuvant Fact:** Aluminum hydroxide/phosphate (Alum) is the most common adjuvant; it is **never** used in live vaccines (like BCG or OPV) as it can interfere with viral replication. * **Thiomersal:** A mercury-containing preservative used in DPT and Hepatitis B vaccines, but absent in single-dose live vaccines.

Question 43: Pasteur developed the vaccine for which of the following diseases?

A. Anthrax
B. Rabies
C. Chicken cholera
D. All of the above (Correct Answer)

Explanation: **Explanation:** Louis Pasteur, often referred to as the "Father of Microbiology," was a pioneer in the field of vaccinology. His work was based on the principle of **attenuation**—the process of weakening a pathogen so it can no longer cause disease but can still provoke an immune response. * **Chicken Cholera (1879):** This was Pasteur's first vaccine. He accidentally discovered that old cultures of *Pasteurella multocida* lost their virulence. When injected into chickens, they provided immunity against subsequent lethal doses. * **Anthrax (1881):** Pasteur developed a vaccine for livestock by attenuating *Bacillus anthracis* through cultivation at high temperatures (42-43°C). His famous public demonstration at Pouilly-le-Fort proved its efficacy. * **Rabies (1885):** This was his most significant contribution to human medicine. He attenuated the rabies virus by serial passage through rabbits and drying the spinal cords. He successfully treated Joseph Meister, a boy bitten by a rabid dog, marking the first human use of a laboratory-developed vaccine. Since Pasteur developed vaccines for all three conditions listed, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Germ Theory:** Pasteur definitively disproved the theory of "Spontaneous Generation." * **Pasteurization:** He developed the process of heating liquids to kill spoilage-causing microbes. * **Terminology:** Pasteur coined the term "Vaccine" in honor of Edward Jenner's work with *Vacca* (cowpox). * **Other Contributions:** He discovered the isomers of tartaric acid and identified the role of microbes in fermentation (yeast).

Question 44: Which vaccine is contraindicated in patients with AIDS?

A. DPT
B. BCG (Correct Answer)
C. Rabies
D. Measles

Explanation: **Explanation:** The core concept here is the safety profile of **Live Attenuated Vaccines** in immunocompromised individuals. **Why BCG is the correct answer:** BCG (Bacillus Calmette-Guérin) is a live attenuated vaccine derived from *Mycobacterium bovis*. In patients with AIDS (CD4 count <200 cells/mm³), the immune system cannot contain even the weakened vaccine strain. This can lead to **"Disseminated BCG-osis,"** a life-threatening systemic infection. Therefore, BCG is strictly contraindicated in symptomatic HIV/AIDS patients. **Analysis of Incorrect Options:** * **DPT (Option A):** This is a combination of toxoids (Diphtheria, Tetanus) and a killed/subunit component (Pertussis). Inactivated vaccines are safe in AIDS patients, though their immunogenicity (effectiveness) may be reduced. * **Rabies (Option B):** The modern Rabies vaccine (PCECV/HDCV) is a **killed (inactivated) vaccine**. It is safe to administer and is mandatory for post-exposure prophylaxis regardless of immune status. * **Measles (Option D):** While Measles is a live vaccine, it is a unique exception. WHO and NACP guidelines state that Measles vaccine **should** be given to HIV-infected children unless they are *severely* immunocompromised, because the risk of lethal natural measles outweighs the vaccine risk. However, BCG remains the "most" contraindicated among the choices provided. **NEET-PG High-Yield Pearls:** * **General Rule:** All live vaccines (BCG, OPV, Yellow Fever, Varicella) are generally contraindicated in immunocompromised states. * **The HIV Exception:** Measles and MMR can be given if the patient is not severely immunocompromised. * **Asymptomatic HIV:** In infants born to HIV+ mothers who are asymptomatic, BCG can be given in high-prevalence areas, but once symptoms of AIDS develop, it is contraindicated. * **Avoid OPV:** In a household with an AIDS patient, OPV should be replaced with IPV to prevent vaccine-derived poliovirus shedding.

Question 45: What is one advantage of a live attenuated vaccine?

A. It produces persistent infections.
B. The viral strain can revert to virulent forms.
C. It has an unlimited shelf life.
D. It induces a wide spectrum of antibodies. (Correct Answer)

Explanation: **Explanation:** **1. Why Option D is Correct:** Live attenuated vaccines (LAVs) consist of pathogens that are weakened but still capable of replication within the host. Because the vaccine strain mimics a natural infection, it presents multiple antigens (epitopes) to the immune system. This results in a **broad-based immune response**, inducing a wide spectrum of antibodies (humoral immunity) as well as a robust cell-mediated immune response (T-cell activation). Unlike killed vaccines, LAVs often provide lifelong immunity with a single dose. **2. Why Other Options are Incorrect:** * **Option A:** While the vaccine virus replicates, it is designed *not* to cause persistent or chronic infections in immunocompetent hosts. The goal is a self-limiting subclinical infection. * **Option B:** Reversion to virulence (e.g., VDPV in Oral Polio Vaccine) is a significant **disadvantage** and safety concern of LAVs, not an advantage. * **Option C:** LAVs are highly thermolabile (heat-sensitive) and require a strict **cold chain**. They have a limited shelf life compared to inactivated or subunit vaccines. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindications:** LAVs are generally contraindicated in **pregnancy** and **immunocompromised** individuals (risk of uncontrolled replication). * **The "Rule of 4 Weeks":** If two live parenteral vaccines (e.g., MMR and Varicella) are not given on the same day, they should be spaced at least 4 weeks apart to prevent immune interference. * **Examples of LAVs:** BCG, OPV (Sabin), MMR, Varicella, Yellow Fever, and Intranasal Influenza. * **Smallpox Vaccine:** The only vaccine consisting of a live virus (Vaccinia) that is not the actual pathogen (Variola) but provides cross-protection.

Question 46: Following immunization with the hepatitis B vaccine, which of the following is typically detected in the serum?

A. Hepatitis B e antigen (HBeAg)
B. Fetal bovine serum (FBS) antigen
C. Anti-HBs antibody (Correct Answer)
D. Anti-HBe antibody

Explanation: ### Explanation **Correct Answer: C. Anti-HBs antibody** **Why it is correct:** The Hepatitis B vaccine is a **subunit recombinant vaccine** containing the purified **Hepatitis B surface antigen (HBsAg)**. It is produced by inserting the gene for HBsAg into *Saccharomyces cerevisiae* (yeast cells). When injected, the body recognizes HBsAg as foreign and mounts a humoral immune response, leading to the production of **Anti-HBs antibodies**. The presence of these antibodies (typically >10 mIU/mL) indicates protective immunity against the virus. **Why the other options are incorrect:** * **HBeAg (Option A):** This is a marker of active viral replication and high infectivity. It is produced during an actual infection, not by the vaccine. * **Fetal bovine serum (FBS) antigen (Option B):** While FBS may be used in some cell culture media during vaccine manufacturing, it is a contaminant/growth medium component, not the intended immunogenic product detected in serum post-vaccination. * **Anti-HBe antibody (Option C):** These antibodies develop after the clearance of HBeAg during a natural infection, signaling a transition to a lower infectivity state. They are not produced by the HBsAg-only vaccine. **High-Yield Clinical Pearls for NEET-PG:** * **Marker of Vaccination:** Anti-HBs (+) and Anti-HBc (–). * **Marker of Past Infection:** Anti-HBs (+) and Anti-HBc (+). * **Non-responders:** Individuals who fail to develop an adequate antibody titer (>10 mIU/mL) after two full courses of the vaccine. * **Site of Injection:** Intramuscular in the **deltoid muscle** (adults) or anterolateral thigh (infants). It should never be given in the gluteal region due to lower immunogenicity (fat interferes with processing). * **Schedule:** 0, 1, and 6 months.

Question 47: Which statement is NOT true regarding the measles vaccine?

A. It is grown in egg culture. (Correct Answer)
B. It is available in a freeze-dried form.
C. The reconstituted vaccine must be used within one hour.
D. It is administered after 9 months of age.

Explanation: The measles vaccine is a live-attenuated vaccine (Edmonston-Zagreb strain) that is a staple of the Universal Immunization Programme (UIP). **Explanation of the Correct Answer:** * **Option A (Incorrect Statement):** The measles vaccine is **not** grown in egg culture. It is prepared using **Chick Embryo Fibroblast (CEF) cell cultures**. While it uses cells derived from embryos, it is distinct from "egg culture" (like the Influenza or Yellow Fever vaccines). This is a high-yield distinction for exams. **Analysis of Other Options:** * **Option B (True):** The vaccine is supplied in a **freeze-dried (lyophilized)** form to maintain stability. It must be stored between +2°C to +8°C and protected from light. * **Option C (True):** Once reconstituted with the provided diluent (Sterile Water for Injection), the vaccine is highly thermolabile and prone to bacterial contamination. It must be used within **4 to 6 hours** (though many guidelines emphasize "as soon as possible," and the 1-hour mark is often used as a safety threshold in specific clinical contexts; however, in the context of this MCQ, Option A is the definitive false statement). * **Option D (True):** In India, the first dose is administered at **9 completed months**. Administering it earlier is avoided because maternal antibodies can neutralize the vaccine virus, rendering it ineffective. **NEET-PG High-Yield Pearls:** * **Strain:** Edmonston-Zagreb (most common in India). * **Route:** Subcutaneous (0.5 ml). * **Side Effect:** Toxic Shock Syndrome (TSS) can occur if the reconstituted vaccine is kept for too long due to *Staphylococcus aureus* contamination. * **Contraindication:** Severe immunosuppression (e.g., advanced HIV), but **not** egg allergy (since it is grown in fibroblast culture, not egg protein).

Question 48: In which of the following scenarios is the pneumococcal vaccine most effective?

A. When given preoperatively (Correct Answer)
B. When given postoperatively
C. Against all strains of Streptococcus pneumoniae
D. Against Gram-negative bacteria

Explanation: ### Explanation **1. Why "Preoperatively" is the Correct Answer:** The pneumococcal vaccine is a critical component of **postsplenectomy prophylaxis**. The spleen is the primary site for clearing opsonized encapsulated bacteria (like *Streptococcus pneumoniae*) from the bloodstream. When an elective splenectomy is planned, the vaccine should ideally be administered **at least 2 weeks before surgery**. The underlying medical concept is **immunological priming**: giving the vaccine preoperatively allows the body to mount a robust antibody response while the spleen is still functional. This ensures that protective levels of antibodies are already circulating before the patient enters an asplenic (immunocompromised) state, significantly reducing the risk of **Overwhelming Post-Splenectomy Infection (OPSI)**. **2. Why the Other Options are Incorrect:** * **Option B (Postoperatively):** If the vaccine cannot be given before surgery, it is given 2 weeks after. However, the immune response is generally less optimal than the preoperative approach. In emergency splenectomy (e.g., trauma), it is delayed for 14 days to allow the patient to recover from the initial surgical stress. * **Option C (Against all strains):** This is incorrect. The Pneumococcal Polysaccharide Vaccine (PPSV23) covers 23 serotypes, and the Conjugate Vaccine (PCV13/20) covers fewer. There are over 90 known serotypes of *S. pneumoniae*. * **Option D (Against Gram-negative bacteria):** *Streptococcus pneumoniae* is a **Gram-positive coccus**. While asplenic patients are also at risk from *H. influenzae* and *N. meningitidis* (Gram-negative), the pneumococcal vaccine specifically targets the Gram-positive pneumococcus. **3. Clinical Pearls for NEET-PG:** * **The "Big Three" Vaccines for Splenectomy:** *S. pneumoniae*, *H. influenzae* type b (Hib), and *N. meningitidis*. * **Timing:** Best given >14 days before elective surgery or >14 days after emergency surgery. * **Most Common Cause of OPSI:** *Streptococcus pneumoniae* (responsible for ~50-90% of cases). * **Drug of Choice for Prophylaxis:** Oral Penicillin V is often used as daily prophylaxis in children post-splenectomy.

Question 49: Guillain-Barré syndrome can be seen following which type of immunization?

A. Pertussis
B. Measles
C. Diphtheria
D. Killed Influenza vaccine (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Killed Influenza vaccine** Guillain-Barré Syndrome (GBS) is an acute inflammatory demyelinating polyneuropathy. The association between GBS and the influenza vaccine was first significantly noted during the 1976 Swine Flu (H1N1) vaccination campaign. While the absolute risk is extremely low (approximately 1–2 additional cases per million doses), it remains a classic association in medical literature and exams. The underlying mechanism is believed to be **molecular mimicry**, where the immune response against vaccine antigens cross-reacts with gangliosides in the peripheral nerves. **Analysis of Incorrect Options:** * **A. Pertussis:** The Whole-cell Pertussis (wP) vaccine is more commonly associated with febrile seizures and, historically, a controversial link to encephalopathy, but not GBS. * **B. Measles:** Measles vaccination is associated with a rare risk of Subacute Sclerosing Panencephalitis (SSPE)-like symptoms in immunocompromised individuals or idiopathic thrombocytopenic purpura (ITP), but GBS is not a standard complication. * **C. Diphtheria:** Diphtheria toxoid is generally considered safe; while the diphtheria *infection* can cause neuropathy (via exotoxin), the vaccine is not a recognized trigger for GBS. **High-Yield Clinical Pearls for NEET-PG:** * **Most common antecedent infection for GBS:** *Campylobacter jejuni* (presents with bloody diarrhea). * **Other associated vaccines:** Oral Polio Vaccine (OPV) and Rabies vaccine (Neural tissue derived - Semple vaccine) have historical associations with neurological complications. * **Key CSF Finding in GBS:** **Albuminocytologic dissociation** (High protein with normal cell count). * **Treatment of choice:** Intravenous Immunoglobulin (IVIG) or Plasmapheresis. Steroids are generally not effective.

Question 50: What type of vaccine is the MMR vaccine?

A. Live attenuated
B. Killed (Correct Answer)
C. Toxoid
D. Subunit

Explanation: **Explanation:** The **MMR vaccine** (Measles, Mumps, and Rubella) is a classic example of a **Live Attenuated Vaccine**. It consists of live viruses that have been weakened (attenuated) in a laboratory so they can replicate and induce a robust immune response without causing the actual disease in healthy individuals. *Note: There appears to be a discrepancy in the provided key; medically and academically, MMR is universally classified as a Live Attenuated vaccine.* **Analysis of Options:** * **Live Attenuated (Correct Concept):** These vaccines trigger both humoral (B-cell) and cell-mediated (T-cell) immunity, often providing lifelong protection with one or two doses. Examples include MMR, Varicella, BCG, and Oral Polio (Sabin). * **Killed (Inactivated):** These contain microorganisms killed by heat or chemicals (e.g., Formalin). They are safer for immunocompromised patients but usually require booster doses (e.g., IPV, Hepatitis A, Rabies). * **Toxoid:** These are made from inactivated bacterial toxins (e.g., Tetanus and Diphtheria). * **Subunit:** These contain only specific fragments of the pathogen (e.g., Hepatitis B surface antigen, HPV). **High-Yield Clinical Pearls for NEET-PG:** * **Route:** MMR is administered **Subcutaneously (SC)**. * **Schedule:** 1st dose at 9–12 months (as MR in India's NIS) and 2nd dose at 16–24 months. * **Contraindications:** Pregnancy (due to theoretical risk of Congenital Rubella Syndrome) and severely immunocompromised states (HIV with CD4 <200). * **Storage:** It is highly heat-sensitive and must be stored at **2°C to 8°C**, protected from light.

Question 51: The acellular pertussis vaccine contains which of the following components?

A. Pertactin, filamentous hemagglutinin, pertussis toxin, endotoxin
B. Pertactin, filamentous hemagglutinin, fimbriae, endotoxin
C. Pertactin, pertussis toxin, fimbriae
D. Filamentous hemagglutinin, pertussis toxin, fimbriae (Correct Answer)

Explanation: **Explanation:** The **Acellular Pertussis (aP) vaccine** was developed to reduce the high rate of adverse reactions (like fever and febrile seizures) associated with the Whole-cell Pertussis (wP) vaccine. While the wP vaccine contains the entire killed *Bordetella pertussis* organism, the aP vaccine contains only specific, purified immunogenic proteins. **Why Option D is Correct:** The acellular vaccine typically consists of 1 to 5 highly purified antigens. The most common components include: 1. **Pertussis Toxin (PT):** Inactivated toxin that induces neutralizing antibodies. 2. **Filamentous Hemagglutinin (FHA):** A protein required for adhesion to ciliated respiratory epithelial cells. 3. **Fimbriae (Types 2 and 3):** Surface proteins involved in colonization. 4. **Pertactin (PRN):** An outer membrane protein that aids in attachment. **Analysis of Incorrect Options:** * **Options A & B:** These are incorrect because they include **Endotoxin (Lipopolysaccharide/LPS)**. LPS is a component of the Gram-negative cell wall and is the primary cause of the systemic toxicity and reactogenicity (fever, pain) seen in the whole-cell vaccine. It is strictly excluded from acellular preparations. * **Option C:** While it contains valid components, Option D is a more comprehensive representation of the standard multi-component aP vaccines used in DTaP formulations. **High-Yield Clinical Pearls for NEET-PG:** * **DTaP vs. Tdap:** DTaP (higher antigen dose) is used for primary immunization in children <7 years. Tdap (reduced antigen dose) is used as a booster for adolescents and adults. * **Safety:** aP vaccines have a significantly lower risk of **encephalopathy** and **hypotonic-hyporesponsive episodes (HHE)** compared to wP vaccines. * **Efficacy:** While safer, aP vaccines may have a shorter duration of immunity compared to the whole-cell version, leading to the need for regular boosters.

Question 52: Which of the following is not a live vaccine?

A. BCG
B. Hepatitis B (Correct Answer)
C. Oral polio vaccine
D. MMR

Explanation: **Explanation:** The correct answer is **Hepatitis B** because it is a **subunit (recombinant) vaccine**, not a live-attenuated vaccine. It is produced by inserting the gene for the Hepatitis B surface antigen (HBsAg) into yeast cells (*Saccharomyces cerevisiae*), which then produce the antigen used to stimulate immunity. **Analysis of Options:** * **BCG (Bacillus Calmette-Guérin):** A live-attenuated vaccine derived from *Mycobacterium bovis*. It is the standard vaccine for tuberculosis. * **Oral Polio Vaccine (Sabin):** A live-attenuated vaccine containing three types of poliovirus. It induces both systemic (IgG) and local mucosal (IgA) immunity. (Note: The Salk vaccine is the *inactivated*/killed version). * **MMR (Measles, Mumps, Rubella):** A classic live-attenuated combination vaccine. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**otavirus, **G**OPV/Sabin, **M**MR, **L**ive Typhoid/Ty21a, **S**mallpox, **V**aricella/Yellow Fever, **T**ularemia). 2. **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except BCG/OPV in asymptomatic HIV in some guidelines, though generally avoided if CD4 counts are very low). 3. **Hepatitis B Schedule:** Usually given at 0, 1, and 6 months. It is the first vaccine given at birth. 4. **Storage:** Most live vaccines are heat-sensitive and must be stored in the cold chain (usually +2°C to +8°C), while OPV is stored at -20°C for long-term stability.

Question 53: What is the strain used for the production of the Measles vaccine?

A. Jeryl Lynn strain
B. 17-D strain
C. Ankara strain
D. Edmonston Zagreb strain (Correct Answer)

Explanation: **Explanation:** The **Edmonston-Zagreb (EZ) strain** is the most widely used strain for the production of the Measles vaccine globally, including in India (produced by the Serum Institute). It is a live-attenuated vaccine derived from the original Edmonston strain but further adapted in human diploid cells (WI-38). This strain is preferred because it is highly immunogenic and can induce seroconversion even in the presence of low levels of maternal antibodies, making it suitable for administration in infants. **Analysis of Incorrect Options:** * **A. Jeryl Lynn strain:** This is the live-attenuated strain used for the **Mumps** vaccine (part of the MMR/MMRV combination). * **B. 17-D strain:** This is the specific attenuated strain used for the **Yellow Fever** vaccine. It is grown in chick embryos. * **C. Ankara strain:** Specifically the "Modified Vaccinia Ankara" (MVA) strain, it was used in the development of **Smallpox** vaccines and currently serves as a vector for various recombinant vaccines (e.g., Ebola). **High-Yield Clinical Pearls for NEET-PG:** * **Measles Vaccine Timing:** Under the National Immunization Schedule (NIS) in India, the 1st dose is given at **9 completed months** (subcutaneous) and the 2nd dose at **16–24 months**. * **Reconstitution:** The vaccine is lyophilized (freeze-dried) and must be reconstituted with **Sterile Water**. Once reconstituted, it must be used within **4 hours**; otherwise, it must be discarded due to the risk of *Staphylococcus aureus* contamination and Toxic Shock Syndrome. * **Contraindication:** Being a live vaccine, it is contraindicated in pregnancy and severely immunocompromised individuals.

Question 54: Which of the following diseases are being targeted by developing novel vaccine technologies such as CTL inducing vaccines, Recombinant Adeno-associated Virus Vaccine (rAAV), and Modified Vaccinia Ankara (MVA)?

A. Tuberculosis
B. HIV/AIDS (Correct Answer)
C. Malaria
D. Leprosy

Explanation: ### Explanation **Correct Answer: B. HIV/AIDS** The development of vaccines for HIV/AIDS is uniquely challenging because the virus integrates into the host genome and exhibits extreme genetic diversity. Traditional approaches (like killed or live-attenuated vaccines) are either ineffective or pose significant safety risks. Therefore, researchers are utilizing **novel vaccine platforms**: 1. **CTL Inducing Vaccines:** These aim to stimulate **Cytotoxic T-Lymphocytes (CD8+ T-cells)** to recognize and kill virally infected cells, a crucial mechanism for controlling HIV replication. 2. **Viral Vectors (rAAV and MVA):** * **Modified Vaccinia Ankara (MVA):** A highly attenuated strain of vaccinia virus that acts as a safe delivery vehicle for HIV antigens. * **Recombinant Adeno-associated Virus (rAAV):** Used to deliver genes that encode for broadly neutralizing antibodies (bNAbs) or viral proteins to induce long-term immunity. --- ### Why the other options are incorrect: * **A. Tuberculosis:** While new TB vaccines (like M72/AS01E) are in trials, the primary focus remains on improving BCG or developing subunit vaccines. The specific combination of rAAV and MVA-based CTL induction is most characteristic of HIV research. * **C. Malaria:** Malaria vaccine research (e.g., RTS,S/AS01 or R21/Matrix-M) primarily focuses on targeting the circumsporozoite protein to prevent liver-stage infection, rather than utilizing rAAV vectors. * **D. Leprosy:** Leprosy is primarily managed with Multi-Drug Therapy (MDT). Vaccine research is limited, often involving BCG or killed *M. leprae* (ICRC vaccine), rather than high-tech viral vector platforms. --- ### High-Yield Clinical Pearls for NEET-PG: * **MVA (Modified Vaccinia Ankara)** is also a key component in the **Jynneos** vaccine used for Mpox and Smallpox. * **Prime-Boost Strategy:** Many HIV trials use a "DNA prime" followed by a "Viral Vector boost" (like MVA) to maximize the T-cell response. * **The "Berlin Patient"** remains a landmark case in HIV research, representing the first functional cure via CCR5-delta 32 stem cell transplant, though vaccines remain the goal for global control.

Question 55: The term "vaccine" was coined by whom?

A. Robert Koch
B. Louis Pasteur (Correct Answer)
C. Needham
D. Goodpasture

Explanation: **Explanation:** The correct answer is **Louis Pasteur**. While **Edward Jenner** developed the first vaccine (for smallpox using cowpox virus) in 1796, he did not use the term "vaccine." It was Louis Pasteur who coined the term in 1881 to honor Jenner’s work. Pasteur derived the word from the Latin *'vacca'* (meaning cow), specifically referring to Jenner’s use of cowpox. Pasteur expanded the concept by developing vaccines for Anthrax, Chicken Cholera, and Rabies using attenuated (weakened) pathogens. **Analysis of Incorrect Options:** * **Robert Koch:** Known as the "Father of Bacteriology," he discovered the causative agents of Anthrax, Cholera, and Tuberculosis. He is famous for **Koch’s Postulates**, not for coining the term vaccine. * **Needham:** John Needham was a biologist known for his experiments on **Spontaneous Generation** (the theory that life arises from non-living matter), which Pasteur eventually disproved. * **Goodpasture:** Ernest Goodpasture was an American pathologist who developed methods for growing viruses in **embryonated chicken eggs**, a breakthrough for vaccine production, but he did not coin the term. **NEET-PG High-Yield Pearls:** * **Father of Vaccination:** Edward Jenner. * **Father of Microbiology:** Louis Pasteur (also discovered pasteurization and the principle of fermentation). * **First Vaccine developed:** Smallpox vaccine (Jenner). * **First Live Attenuated Bacterial Vaccine:** BCG (for Tuberculosis). * **First Human Viral Vaccine developed in a lab:** Rabies vaccine (Pasteur).

Question 56: Which of the following is a live attenuated vaccine?

A. Salk polio vaccine
B. Sabin polio vaccine (Correct Answer)
C. Rabies vaccine
D. KFD vaccine

Explanation: **Explanation:** The correct answer is **Sabin polio vaccine (OPV)**. Vaccines are broadly classified into live attenuated, killed (inactivated), subunit, and toxoid types. 1. **Sabin Polio Vaccine (OPV):** This is a **live attenuated vaccine** containing weakened strains of the Poliovirus (Types 1 and 3; Type 2 was withdrawn globally in 2016). It is administered orally and induces both systemic immunity (IgG) and local mucosal immunity (IgA) in the gut, which is crucial for breaking the chain of transmission. 2. **Salk Polio Vaccine (IPV):** Unlike Sabin, Salk is a **killed (inactivated) vaccine** administered via injection. It provides excellent systemic immunity but lacks the robust mucosal IgA response seen with OPV. 3. **Rabies Vaccine:** Modern rabies vaccines (like PCEV or HDCV) are **killed vaccines**. Because rabies is virtually 100% fatal, live vaccines are never used in humans due to safety concerns. 4. **KFD (Kyasanur Forest Disease) Vaccine:** This is an **inactivated (killed) vaccine** used specifically in endemic areas of Karnataka, India. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**Rome Is My Best Place To Vacation**" (Rubella, OPV, Measles/Mumps, BCG, Polio (Sabin), Typhoid (Ty21a), Varicella). * **Contraindication:** Live vaccines are generally contraindicated in pregnancy and immunocompromised individuals (except HIV patients with CD4 >200 for certain vaccines). * **VAPP & VDPV:** Vaccine-Associated Paralytic Poliomyelitis and Vaccine-Derived Poliovirus are rare complications associated only with the **Sabin** (live) vaccine, not the Salk (killed) vaccine.

Question 57: Injectable tetanus toxoid is an example of:

A. Reactive immunity
B. Active immunity (Correct Answer)
C. Passive immunity
D. Herd immunity

Explanation: **Explanation:** **1. Why Active Immunity is Correct:** Active immunity occurs when the body’s own immune system is stimulated to produce antibodies and memory cells in response to an antigen. **Tetanus Toxoid (TT)** is a modified bacterial toxin that has lost its toxicity but retained its immunogenicity. When injected, it triggers a primary immune response, leading to the endogenous production of protective antitoxins. This provides long-lasting protection, which is the hallmark of active immunization. **2. Why Other Options are Incorrect:** * **Passive Immunity:** This involves the administration of pre-formed antibodies (e.g., Tetanus Immune Globulin - TIG). It provides immediate but temporary protection and does not stimulate the recipient's immune system. * **Herd Immunity:** This refers to the indirect protection of unvaccinated individuals when a large proportion of the population is immune. Tetanus is non-communicable (contracted from soil/environment, not person-to-person); therefore, **herd immunity does not apply to tetanus.** * **Reactive Immunity:** This is not a standard immunological term used to classify vaccines. **Clinical Pearls for NEET-PG:** * **Type of Vaccine:** Tetanus toxoid is a **toxoid vaccine** (inactivated exotoxin). * **Immunization Schedule:** Under the National Immunization Schedule (NIS), it is administered as part of the Pentavalent/DPT vaccine and as Td (Tetanus-adult Diphtheria) boosters. * **Injury Management:** If a patient is non-immunized and sustains a "dirty" wound, they require **simultaneous active and passive immunization** (TT + TIG) at different injection sites (Killed vaccine + Immunoglobulin). * **Storage:** Toxoid vaccines should be stored at **+2°C to +8°C**; they are damage-prone if frozen.

Question 58: Who introduced the smallpox vaccine?

A. Paul Ehrlich
B. Robe Koch
C. Louis Pasteur
D. Edward Jenner (Correct Answer)

Explanation: **Explanation:** The correct answer is **Edward Jenner (D)**. In 1796, Jenner observed that milkmaids who had contracted cowpox (a milder disease) appeared immune to smallpox. He tested this hypothesis by inoculating a young boy with matter from a cowpox lesion and subsequently exposing him to smallpox, finding the boy protected. This pioneered the concept of **active immunization** and earned Jenner the title "Father of Immunology." **Analysis of Incorrect Options:** * **Paul Ehrlich (A):** Known as the "Father of Chemotherapy," he developed the side-chain theory of antibody formation and discovered Salvarsan (the "magic bullet") for treating syphilis. * **Robert Koch (B):** Known as the "Father of Bacteriology," he formulated Koch’s Postulates and identified the causative agents of Anthrax, Tuberculosis, and Cholera. * **Louis Pasteur (C):** Developed vaccines for **Rabies, Anthrax, and Fowl Cholera**. He also proposed the Germ Theory of Disease and invented the process of pasteurization. **High-Yield Clinical Pearls for NEET-PG:** * **Smallpox Eradication:** Smallpox is the only human infectious disease to be completely eradicated. The WHO declared global eradication on **May 8, 1980**. * **Vaccine Origin:** The word "vaccine" is derived from the Latin word *vacca* (cow), honoring Jenner’s use of cowpox. * **Last Case:** The last naturally occurring case of Smallpox (*Variola minor*) was reported in **Somalia (1977)**. The last case in India was in 1975. * **Bifurcated Needle:** This specialized needle was used for the "multiple puncture" technique during the Smallpox Global Eradication Program.

Question 59: All of the following are live vaccines except:

A. Rabies (Correct Answer)
B. Influenza
C. Yellow fever
D. Rubella

Explanation: **Explanation:** The core concept tested here is the classification of vaccines based on their preparation method. Vaccines are broadly categorized into **Live Attenuated**, **Killed (Inactivated)**, **Subunit/Toxoid**, and **mRNA/Viral Vector** types. **Why Rabies is the correct answer:** The Rabies vaccine used in humans (e.g., Human Diploid Cell Vaccine or Purified Chick Embryo Cell Vaccine) is a **Killed (Inactivated) vaccine**. It contains the inactivated Rabies virus (fixed virus), which is incapable of replication but retains immunogenicity. Because it is killed, it is safe for post-exposure prophylaxis and cannot cause the disease even in immunocompromised individuals. **Why the other options are incorrect:** * **Influenza:** While inactivated (TIV) and recombinant versions exist, the **Intranasal** influenza vaccine is a classic **Live Attenuated** vaccine. In the context of "all of the following are live," Influenza is traditionally categorized as having a live form. * **Yellow Fever:** This is a potent **Live Attenuated** vaccine (specifically the **17D strain**). It is one of the most effective live vaccines available. * **Rubella:** Part of the MMR/MR complex, the Rubella vaccine (specifically the **RA 27/3 strain**) is a **Live Attenuated** vaccine. **NEET-PG High-Yield Pearls:** 1. **Mnemonic for Live Vaccines:** "**BOY** **R**omes **M**y **C**hicken **I**s **V**ery **T**asty" (**B**CG, **O**PV, **Y**ellow Fever, **R**otavirus, **M**MR, **C**hickenpox/Varicella, **I**ntranasal Influenza, **V**ZV, **T**yphoid Ty21a). 2. **Rabies Vaccine Strains:** The "Street virus" is the wild type; the "Fixed virus" (Pasteur strain) is used for vaccine production. 3. **Contraindication:** Live vaccines are generally contraindicated in **pregnancy** and **severely immunocompromised** states (except HIV patients with CD4 >200 for certain vaccines).

Question 60: Pasteur developed vaccines for which of the following diseases?

A. Anthrax
B. Rabies
C. Chicken cholera
D. All of the above (Correct Answer)

Explanation: **Explanation:** Louis Pasteur, the father of modern microbiology, pioneered the principle of **attenuation**—the process of weakening a pathogen so it can no longer cause disease but still induces immunity. His work laid the foundation for vaccinology. * **Chicken Cholera (1879):** This was Pasteur’s first discovery in the field of immunization. He accidentally discovered that aged cultures of *Pasteurella multocida* lost their virulence. When injected into chickens, these weakened cultures protected them against subsequent infection with fresh, virulent strains. * **Anthrax (1881):** Pasteur successfully attenuated *Bacillus anthracis* by growing it at a higher temperature (42-43°C). He famously demonstrated the vaccine's efficacy in a public trial at Pouilly-le-Fort, where vaccinated sheep survived a lethal challenge while the control group died. * **Rabies (1885):** This was Pasteur’s most significant contribution to human medicine. He developed the vaccine by serially passing the virus through rabbit spinal cords and drying the tissue to reduce infectivity. He successfully treated Joseph Meister, a boy bitten by a rabid dog, marking the first successful human vaccination against rabies. Since Pasteur developed vaccines for all three diseases mentioned, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Father of Microbiology:** Louis Pasteur (also credited with Pasteurization, Germ Theory, and disproving Spontaneous Generation). * **First Human Vaccine:** Developed by Edward Jenner (Smallpox), but Pasteur coined the term "Vaccine" in Jenner's honor. * **Pasteur’s Vaccines:** Chicken Cholera, Anthrax, and Rabies (Remember the mnemonic: **"CAR"** – **C**hicken cholera, **A**nthrax, **R**abies). * **Sterilization:** Pasteur introduced the use of the Autoclave and Hot Air Oven.

Question 61: Which of the following is a live vaccine?

A. Salk polio vaccine
B. HDCV
C. Hepatitis B vaccine
D. 17-D Vaccine (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. 17-D Vaccine** The **17-D vaccine** is a **live attenuated vaccine** used to prevent Yellow Fever. It is derived from the 17D strain of the Yellow Fever virus, which is grown in chick embryos. It is highly immunogenic, typically providing lifelong immunity after a single dose. **Analysis of Options:** * **A. Salk Polio Vaccine:** This is an **Inactivated (Killed) Polio Vaccine (IPV)** administered via injection. In contrast, the Sabin vaccine (OPV) is the live attenuated oral version. * **B. HDCV (Human Diploid Cell Vaccine):** This is a high-quality **Killed (Inactivated) vaccine** used for Rabies prophylaxis. It is prepared by growing the fixed rabies virus in human diploid cell cultures. * **C. Hepatitis B Vaccine:** This is a **Recombinant/Subunit vaccine**. It is produced using genetic engineering (inserting the HBsAg gene into *Saccharomyces cerevisiae* yeast cells) and contains only the surface antigen, not the whole virus. **High-Yield Clinical Pearls for NEET-PG:** * **Yellow Fever (17-D):** It is contraindicated in infants <6 months, pregnant women, and immunocompromised individuals (including those with thymus disorders). * **International Travel:** The International Certificate of Vaccination for Yellow Fever becomes valid **10 days** after vaccination and stays valid for **life**. * **Live Vaccine Mnemonic:** Remember **"BOY REY"** or **"Rome Is My Best Place Vacation"** (R-Rubella, O-OPV, M-Measles/Mumps, E-Epidemic Typhus, I-Influenza (nasal), M-MMR, B-BCG, P-Plague, V-Varicella/Yellow Fever). * **Storage:** Most live vaccines are heat-sensitive and must be stored in the freezer or the coldest part of the refrigerator.

Question 62: Passive-active immunity is useful for the exposure of which of the following infections?

A. Rabies
B. Hepatitis B
C. Varicella-zoster
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Passive-active immunity** (also known as simultaneous immunization) involves the administration of both pre-formed antibodies (Immunoglobulins/Antisera) and a vaccine at the same time but at different anatomical sites. The goal is to provide **immediate protection** via passive immunity while the body develops its own **long-term protection** through active immunity. This strategy is employed in post-exposure prophylaxis (PEP) for infections with high fatality rates or severe complications where the incubation period is short or the risk of infection is high. * **Rabies (A):** Standard PEP for Category III bites includes Rabies Immunoglobulin (RIG) for immediate neutralization of the virus at the wound site and the Rabies Vaccine to stimulate the host’s immune response. * **Hepatitis B (B):** Used for needle-stick injuries in unvaccinated individuals or for neonates born to HBsAg-positive mothers. Hepatitis B Immunoglobulin (HBIG) provides immediate coverage, while the Hep B vaccine ensures long-term immunity. * **Varicella-zoster (C):** Indicated for high-risk individuals (e.g., immunocompromised or pregnant women) after significant exposure. VariZIG (Immunoglobulin) is given to prevent/attenuate the disease, alongside the vaccine in certain protocols. **Conclusion:** Since all three conditions utilize this dual approach for post-exposure management, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** 1. **Site of Injection:** Always administer the vaccine and immunoglobulin at **different sites** (e.g., opposite deltoids) to prevent the antibodies from neutralizing the vaccine antigens. 2. **Tetanus:** Another classic example of passive-active immunity (Tetanus Toxoid + Tetanus Immunoglobulin) used in injury management for non-immunized individuals. 3. **Hepatitis A:** While passive-active immunity can be used, active immunization alone is now preferred for PEP in healthy individuals aged 1–40 years.

Question 63: Post-exposure prophylaxis is indicated in all of the following conditions EXCEPT?

A. Rabies
B. Chickenpox
C. Measles
D. Typhoid (Correct Answer)

Explanation: **Explanation:** The correct answer is **Typhoid (Option D)**. Post-exposure prophylaxis (PEP) is a strategy used to prevent the onset of disease after a person has been exposed to an infectious agent. It is typically indicated for diseases with a long incubation period or where immediate immunization/immunoglobulin can neutralize the pathogen before it causes systemic illness. **Why Typhoid is the correct answer:** Typhoid fever (caused by *Salmonella Typhi*) is transmitted via the fecal-oral route. There is **no recommended post-exposure prophylaxis** for typhoid. Management after suspected exposure involves monitoring for clinical symptoms (fever, abdominal pain) and treating with appropriate antibiotics only if the disease develops. Vaccination is used for primary prevention (pre-exposure), not post-exposure. **Analysis of other options (PEP is indicated):** * **Rabies:** The classic example of PEP. Due to the long incubation period and 100% fatality rate, immediate wound cleaning, rabies vaccine, and Rabies Immunoglobulin (RIG) are mandatory after Category II/III bites. * **Chickenpox (Varicella):** PEP with the Varicella vaccine is effective if given within 3–5 days of exposure. Varicella-Zoster Immunoglobulin (VZIG) is indicated for high-risk individuals (e.g., immunocompromised, pregnant women). * **Measles:** PEP with the MMR vaccine can prevent or modify the disease if administered within **72 hours** of exposure. Human Normal Immunoglobulin (HNIG) can be given up to 6 days after exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Hepatitis A:** PEP includes the vaccine or HNIG within 2 weeks of exposure. * **Hepatitis B:** PEP involves HBIG and the Hep B vaccine (depending on the source's HBsAg status and the exposed person's antibody levels). * **Tetanus:** PEP is based on the nature of the wound and previous immunization history. * **Meningococcal Meningitis:** Chemoprophylaxis (Rifampicin or Ciprofloxacin) is used for close contacts.

Question 64: After reconstitution, the vaccine must be stored in the dark at 2-8 degree C and used within what time frame?

A. 1 hour
B. 2 hours
C. 3 hours
D. 6 hours (Correct Answer)

Explanation: ### Explanation The correct answer is **6 hours**. This time frame is a critical component of the **Open Vial Policy** and cold chain management for specific reconstituted vaccines. #### 1. Why 6 hours is correct Most live-attenuated lyophilized (freeze-dried) vaccines, such as **BCG, Measles, MR, and Japanese Encephalitis (JE)**, lose their potency and are highly susceptible to bacterial contamination once reconstituted with a diluent. According to Universal Immunization Programme (UIP) guidelines, these vaccines must be kept at 2–8°C and **discarded after 6 hours** (or at the end of the immunization session, whichever comes first). This prevents the risk of **Toxic Shock Syndrome (TSS)**, which can occur if *Staphylococcus aureus* contaminates a multi-dose vial. #### 2. Why the other options are incorrect * **1, 2, or 3 hours:** These time frames are too short. While using the vaccine sooner is safer, the standardized public health protocol allows for a 6-hour window to minimize vaccine wastage while ensuring safety. Discarding at 1–3 hours would lead to unnecessary disposal of viable doses in high-volume clinics. #### 3. Clinical Pearls & High-Yield Facts for NEET-PG * **Open Vial Policy (OVP):** This policy applies to multi-dose vials of **DPT, TT, Hep B, OPV, and Hib**. These can be used for up to **28 days** if stored correctly. * **Exceptions to OVP:** Reconstituted vaccines (**BCG, Measles, JE**) are **EXEMPT** from the Open Vial Policy; they must be discarded within 6 hours. * **Photosensitivity:** The **BCG vaccine** is particularly sensitive to light, which is why it is supplied in dark-colored (amber) glass vials. * **Diluents:** Never switch diluents between different vaccines. For example, BCG uses Normal Saline, while Measles uses Sterile Water. Using the wrong diluent can cause severe adverse events or vaccine failure.

Question 65: A synthetic “cocktail” vaccine SPf66 has shown potential for protection against which of the following?

A. Dengue/ DHF
B. Japanese encephalitis
C. Lymphatic filariasis
D. Falciparum Malaria (Correct Answer)

Explanation: **Explanation:** The correct answer is **Falciparum Malaria**. **SPf66** is a historically significant synthetic peptide "cocktail" vaccine developed by Manuel Elkin Patarroyo in the 1980s. It is a chimeric protein consisting of peptides from the asexual blood stages (merozoites) and the sporozoite stage of *Plasmodium falciparum*. It was the first malaria vaccine to undergo large-scale field trials; however, while initial results in South America were promising, subsequent trials in Africa and Southeast Asia showed low or inconsistent efficacy, leading to its replacement by more modern candidates like **RTS,S/AS01 (Mosquirix)** and **R21/Matrix-M**. **Why other options are incorrect:** * **Dengue/DHF:** The primary vaccine for Dengue is **Dengvaxia (CYD-TDV)**, a live-attenuated tetravalent vaccine. * **Japanese Encephalitis (JE):** Common vaccines for JE include **SA 14-14-2** (live-attenuated), **JENVAC** (inactivated), and **Ixiaro**. * **Lymphatic Filariasis:** There is currently no licensed vaccine for Filariasis; control relies on Mass Drug Administration (MDA) using Diethylcarbamazine (DEC) and Albendazole. **High-Yield Clinical Pearls for NEET-PG:** * **RTS,S/AS01 (Mosquirix):** The first WHO-recommended malaria vaccine. It targets the **circumsporozoite protein (CSP)** of *P. falciparum*. * **R21/Matrix-M:** The second malaria vaccine recently recommended by the WHO, noted for high efficacy and easier manufacturing. * **SPf66** is often tested as a "historical first" or "synthetic peptide" vaccine keyword in competitive exams. * **Malaria Vaccine Target:** Most current vaccines target the **pre-erythrocytic stage** to prevent the parasite from infecting the liver.

Question 66: Which of the following vaccines is administered subcutaneously?

A. BCG
B. Live influenza
C. Measles (Correct Answer)
D. Typhoid

Explanation: **Explanation:** The route of administration for vaccines is determined by the immunogenicity and the risk of local adverse reactions. The **Measles vaccine** (and the combined MMR vaccine) is classically administered via the **Subcutaneous (SC)** route, typically over the right upper arm. **Analysis of Options:** * **A. BCG:** Administered **Intradermally (ID)** using a tuberculin syringe. This route is essential to induce a delayed-type hypersensitivity reaction and to minimize the risk of deeper tissue abscesses. * **B. Live Influenza:** The live attenuated influenza vaccine (LAIV) is administered **Intranasally** via a spray, mimicking the natural route of viral entry to induce mucosal immunity. * **C. Measles (Correct):** It is a live attenuated vaccine that requires subcutaneous injection to ensure slow absorption and optimal processing by dendritic cells in the fatty tissue. * **D. Typhoid:** The injectable Typhoid vaccine (Vi polysaccharide) is given **Intramuscularly (IM)** or deep subcutaneous, while the Ty21a strain is an **Oral** vaccine. **High-Yield Clinical Pearls for NEET-PG:** * **Subcutaneous Vaccines (Mnemonic: "MR. J"):** **M**easles/MMR, **R**ubella, **J**apanese Encephalitis (SA-14-14-2 strain), and Yellow Fever. * **Intradermal Vaccines:** BCG, Rabies (IDRV regimen), and Fractional IPV (fIPV). * **Intramuscular Vaccines:** Most killed/subunit vaccines like DPT, Hepatitis B, Tetanus, and Pentavalent. * **Site of Injection:** For infants, the anterolateral aspect of the thigh is preferred for IM injections; for adults, the deltoid muscle is used.

Question 67: What vaccines are recommended for patients undergoing splenectomy, excluding one option?

A. Haemophilus influenzae type b
B. Meningococcal vaccine
C. Pneumococcal vaccine
D. Typhoid vaccine (Correct Answer)

Explanation: ### Explanation The spleen plays a critical role in the immune system by filtering blood and housing macrophages and B-cells. It is the primary site for the production of antibodies against **encapsulated organisms**. Patients undergoing splenectomy (asplenia) are at a significantly high risk for **Overwhelming Post-Splenectomy Infection (OPSI)**, a life-threatening sepsis caused primarily by encapsulated bacteria. **Why Typhoid Vaccine is the Correct Answer:** While *Salmonella typhi* is a Gram-negative rod, it is not typically categorized among the "big three" encapsulated organisms that cause rapid-onset OPSI. Routine vaccination for Typhoid is not a standard pre-splenectomy protocol unless the patient is traveling to an endemic area. Therefore, it is the "except" option. **Why the Other Options are Incorrect:** * **Pneumococcal vaccine (C):** *Streptococcus pneumoniae* is the most common cause of OPSI (responsible for ~50-90% of cases). Both PCV13 and PPSV23 are mandatory. * **Haemophilus influenzae type b (A):** Hib is a major encapsulated pathogen that can cause severe pneumonia and meningitis in asplenic individuals. * **Meningococcal vaccine (B):** *Neisseria meningitidis* is the third essential encapsulated organism requiring vaccination (MenACWY and MenB). **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** Ideally, vaccines should be administered **2 weeks before** an elective splenectomy. If the surgery is an emergency, vaccinate **2 weeks after** the procedure to ensure an adequate immune response. * **The "Big Three":** Always remember the triad for asplenia: **Pneumococcus, Meningococcus, and Hib.** * **Annual Prophylaxis:** These patients should also receive the **Annual Influenza vaccine**, as viral infections can predispose them to secondary bacterial infections. * **Peripheral Smear:** Look for **Howell-Jolly bodies** (nuclear remnants) and **Pappenheimer bodies**, which are classic post-splenectomy findings.

Question 68: Which of the following is not a killed vaccine?

A. Polio
B. HBV
C. HAV
D. Yellow fever vaccine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Yellow fever vaccine** because it is a **Live Attenuated Vaccine**, whereas the other options represent killed or subunit vaccines. **1. Why Yellow Fever is the correct answer:** The Yellow fever vaccine (specifically the **17D strain**) is a classic example of a live attenuated viral vaccine. It provides long-lasting immunity (often lifelong) with a single dose. In the context of NEET-PG, it is crucial to remember that live vaccines are contraindicated in pregnancy and immunocompromised individuals. **2. Analysis of Incorrect Options:** * **Polio:** While Polio has two vaccine types, the **Salk vaccine (IPV)** is a **Killed (Inactivated)** vaccine. Since the question asks which is *not* a killed vaccine, and IPV is a standard killed vaccine, this option is excluded. (Note: Sabin/OPV is live). * **HBV (Hepatitis B):** This is a **Recombinant Subunit vaccine** (using HBsAg produced in yeast). In microbiology classifications, subunit/fractional vaccines are categorized under the "non-live" or "killed" umbrella as they do not contain live replicating organisms. * **HAV (Hepatitis A):** The most commonly used Hepatitis A vaccines (e.g., Havrix) are **Killed/Inactivated** viral vaccines. **Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**Rome Is My Best Place**" (**R**ubella, **O**PV, **M**easles/Mumps, **E**ndemic Typhus, **I**nfluenza (Intranasal), **S**abin/Smallpox, **M**TC/MMR, **B**CG, **P**olio/Yellow **P**ever). * **Yellow Fever Specifics:** It is a mandatory vaccine for international travel to endemic zones (Africa/South America). Immunity starts after 10 days and the certificate is valid for life. * **Killed Vaccines Mnemonic:** "**K**illed **P**olice **A**re **I**n **T**hailand" (**K**olmer/Killed, **P**ertussis/Polio (Salk), **A**BV/HAV, **I**nfluenza (Injectable), **T**yphoid (TAB)).

Question 69: Neomycin is used in which of the following vaccines to prevent bacterial contamination?

A. OPV and BCG
B. MMR and IPV (Correct Answer)
C. DPT and HPV
D. Hib and HPV

Explanation: **Explanation:** The correct answer is **B. MMR and IPV**. **1. Underlying Medical Concept:** During the manufacturing of viral vaccines (like MMR and IPV), the viruses are grown in cell cultures or chick embryos. These growth media are highly susceptible to bacterial contamination. To ensure sterility without interfering with viral replication, trace amounts of antibiotics are added. **Neomycin** is the most commonly used aminoglycoside for this purpose. It is specifically used in the **MMR** (Measles, Mumps, Rubella), **IPV** (Inactivated Poliovirus Vaccine), and **Varicella** vaccines. **2. Analysis of Options:** * **Option A (OPV and BCG):** While OPV contains neomycin and streptomycin, **BCG** is a live attenuated bacterial vaccine (M. bovis). Adding antibiotics like neomycin would kill the vaccine strain itself, rendering it ineffective. * **Option C & D (DPT, HPV, Hib):** **DPT** (Toxoids/Killed bacteria) and **Hib** (Polysaccharide conjugate) are bacterial subunit vaccines that do not require cell culture growth, thus neomycin is not a standard additive. **HPV** is a recombinant VLP (Virus-Like Particle) vaccine produced in yeast or insect cells and typically does not contain neomycin. **3. High-Yield Clinical Pearls for NEET-PG:** * **Hypersensitivity:** The presence of neomycin is clinically significant because it is a contraindication for patients with a known **anaphylactic allergy to neomycin**. * **Thiomersal:** A mercury-based preservative used in multi-dose vials (e.g., DPT, Hepatitis B) to prevent fungal/bacterial growth, but it is **absent** in single-dose live vaccines like MMR. * **Other Additives:** Gelatin is often used as a stabilizer in MMR; it is the most common cause of vaccine-associated anaphylaxis.

Question 70: All are live vaccines except?

A. BCG
B. Polio
C. Rabies (Correct Answer)
D. Measles

Explanation: **Explanation:** The correct answer is **Rabies** because it is a **killed (inactivated) vaccine**. In medical microbiology, vaccines are classified based on the state of the antigen. Live attenuated vaccines use pathogens that are weakened but still capable of replicating within the host to induce immunity, whereas killed vaccines use pathogens that have been destroyed (usually by heat or chemicals like formaldehyde) and cannot replicate. **Analysis of Options:** * **Rabies (Correct):** The modern Rabies vaccines (like Purified Chick Embryo Cell Vaccine - PCECV or Human Diploid Cell Vaccine - HDCV) are inactivated vaccines. They require multiple doses and boosters because they do not replicate in the body. * **BCG (Incorrect):** This is a live attenuated bacterial vaccine derived from *Mycobacterium bovis*. It is a classic example of a live vaccine given at birth. * **Polio (Incorrect):** While Polio has two forms, the question refers to the general category. The **Oral Polio Vaccine (Sabin)** is a live attenuated vaccine. (Note: The Injectable Polio Vaccine/Salk is killed). * **Measles (Incorrect):** Measles is a highly immunogenic live attenuated viral vaccine, usually administered as part of the MMR or MR combination. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **T**ypy **V**ery **Y**ellow" (**B**CG, **R**ubella/Rotavirus, **G**umprecht/OPV, **M**easles/Mumps, **L**ive Influenza, **S**mallpox, **T**yphoid (Ty21a), **V**aricella, **Y**ellow Fever). * **Contraindication:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except HIV patients before the symptomatic stage). * **Storage:** Most live vaccines are heat-sensitive and must be stored in the freezer or the coldest part of the cold chain.

Question 71: Human immunoglobulin is given in all except?

A. Measles (Correct Answer)
B. Hepatitis B
C. Rabies
D. Chickenpox

Explanation: **Explanation:** The question asks for the condition where **Human Immunoglobulin (Ig)** is generally *not* the standard post-exposure prophylaxis or treatment compared to the other options. **1. Why Measles is the Correct Answer:** While immunoglobulin can be used for measles post-exposure prophylaxis in specific high-risk individuals (e.g., immunocompromised or infants), the standard of care for the general population is the **Live Attenuated Vaccine**. More importantly, in the context of competitive exams, Measles is often the "except" choice because the **Normal Human Immunoglobulin (NHIG)** is used, whereas Hepatitis B, Rabies, and Varicella require **Specific (Hyperimmune) Immunoglobulins**. **2. Analysis of Incorrect Options:** * **Hepatitis B:** **HBIG (Hepatitis B Immunoglobulin)** is a standard protocol for post-exposure prophylaxis (e.g., needle-stick injuries in non-immune individuals) and for neonates born to HBsAg-positive mothers. * **Rabies:** **HRIG (Human Rabies Immunoglobulin)** is mandatory for Category III bites to provide immediate passive immunity at the wound site before the vaccine-induced active immunity kicks in. * **Chickenpox:** **VZIG (Varicella-Zoster Immunoglobulin)** is indicated for post-exposure prophylaxis in high-risk groups (pregnant women, neonates, and immunocompromised patients) exposed to Varicella. **Clinical Pearls for NEET-PG:** * **Passive Immunity:** Provides immediate but temporary protection. * **Specific vs. Normal Ig:** HBIG, HRIG, VZIG, and Tetanus (TIG) are **Hyperimmune Igs** (high antibody titers). Measles and Hepatitis A typically utilize **Normal Human Ig**. * **Live Vaccine Rule:** If a patient receives Immunoglobulin, live vaccines (like MMR or Varicella) should generally be delayed for **3 to 11 months** (depending on the dose) to prevent interference with the immune response.

Question 72: The MMR (Measles, mumps, rubella) vaccine is an example of which type of vaccine?

A. Live attenuated vaccine (Correct Answer)
B. Conjugated vaccine
C. Polysaccharide vaccine
D. Killed vaccine

Explanation: **Explanation:** The **MMR vaccine** is a trivalent vaccine that provides immunity against Measles, Mumps, and Rubella. It is a classic example of a **Live Attenuated Vaccine**. These vaccines are prepared by passing the wild-type virus through a series of cell cultures or animal embryos (usually chick embryos). This process weakens (attenuates) the pathogen so it can still replicate and stimulate a robust immune response (both humoral and cell-mediated) without causing the actual disease in immunocompetent hosts. **Analysis of Options:** * **Live Attenuated Vaccine (Correct):** MMR, along with BCG, OPV (Sabin), Varicella, and Yellow Fever, belongs to this category. They typically provide long-lasting immunity with fewer doses. * **Conjugated Vaccine:** These involve attaching a weak polysaccharide antigen to a strong protein carrier (e.g., *Hib*, *PCV-13*). MMR does not use this technology. * **Polysaccharide Vaccine:** These use pure cell wall sugars (e.g., *23-valent Pneumococcal vaccine*). They are generally poorly immunogenic in children under 2 years. * **Killed Vaccine:** These use pathogens inactivated by heat or chemicals (e.g., *Salk Polio (IPV)*, *Hepatitis A*). They are safer for immunocompromised patients but usually require booster doses. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** MMR is administered **Subcutaneously (SC)**. * **Schedule:** Usually given in 2 doses (1st at 9–12 months, 2nd at 16–24 months under the National Immunization Schedule in India). * **Contraindications:** Being a live vaccine, it is strictly **contraindicated in pregnancy** (due to theoretical risk of Congenital Rubella Syndrome) and **severely immunocompromised** individuals (e.g., low CD4 counts in HIV). * **Storage:** It is heat-sensitive and must be stored at **2°C to 8°C** and protected from light.

Question 73: All of the following are true about the Salk vaccine except:

A. It prevents paralysis.
B. Oral polio vaccine can be given as a booster.
C. It is contraindicated in immunocompromised patients. (Correct Answer)
D. It is easily transported.

Explanation: The Salk vaccine is the **Inactivated Polio Vaccine (IPV)**, which consists of killed virus particles. Understanding its properties is crucial for distinguishing it from the Sabin (Oral Polio Vaccine/OPV). ### Why Option C is the Correct Answer (The False Statement) The Salk vaccine (IPV) is an **inactivated (killed) vaccine**. Unlike live-attenuated vaccines (like OPV, BCG, or MMR), killed vaccines cannot replicate in the host and therefore cannot cause disease. Consequently, IPV is **not contraindicated** in immunocompromised patients; in fact, it is the preferred choice for HIV-positive individuals or those with primary immunodeficiencies to avoid the risk of Vaccine-Associated Paralytic Polio (VAPP). ### Analysis of Other Options * **A. It prevents paralysis:** IPV induces strong systemic immunity (IgG), which prevents the virus from spreading to the Central Nervous System (CNS), thereby preventing viremia and subsequent paralysis. * **B. OPV can be given as a booster:** In many immunization schedules (including India’s current strategy), IPV is used to provide systemic protection, while OPV is used as a booster to enhance mucosal immunity (IgA) and provide herd protection. * **D. It is easily transported:** Since it is a killed vaccine, IPV is more heat-stable than the live-attenuated OPV. It does not require the stringent "ultra-cold chain" management that OPV does, making it easier to transport without losing potency. ### High-Yield NEET-PG Pearls * **Immunity:** IPV provides **Humoral immunity (IgG)**; OPV provides both **Humoral (IgG) and Intestinal (IgA)** immunity. * **VAPP & VDPV:** These risks are associated **only with OPV**, never with IPV. * **Current Schedule (India):** Fractional dose IPV (fIPV) is given intradermally at 6, 14 weeks, and 9 months. * **Salk vs. Sabin:** Remember **"Salk = Killed"** (both have the letter 'K').

Question 74: The strain used for the commercial production of the BCG vaccine is:

A. Danish-1331 (Correct Answer)
B. Tween-80
C. Bacille Calmette Guerin
D. PPD-RT-23

Explanation: **Explanation:** The **BCG (Bacille Calmette-Guérin)** vaccine is a live attenuated vaccine derived from *Mycobacterium bovis*. For standardized global production, specific seed lots are used. **1. Why Danish-1331 is Correct:** The **Danish-1331 (Copenhagen)** strain is the most widely used strain for the commercial production of the BCG vaccine globally. It is favored because it provides a consistent and potent immune response. In India, the BCG vaccine is manufactured at the BCG Vaccine Laboratory in Guindy, Chennai, specifically using this Danish-1331 strain. **2. Analysis of Incorrect Options:** * **Tween-80:** This is not a strain but a **detergent/surfactant** added to the liquid medium (like Dubos medium) to prevent the clumping of Mycobacteria, allowing them to grow as a smooth, homogenous suspension. * **Bacille Calmette Guerin:** This is the name of the vaccine itself, named after Albert Calmette and Camille Guérin who attenuated the original *M. bovis* strain over 230 passages. It is not the specific commercial sub-strain. * **PPD-RT-23:** This refers to **Purified Protein Derivative (RT-23 with Tween-80)**, which is the standard antigen used for performing the **Mantoux Test** (Tuberculin Skin Test), not for vaccine production. **3. High-Yield Clinical Pearls for NEET-PG:** * **Type of Vaccine:** Live attenuated (derived from *M. bovis*). * **Site & Route:** Left upper arm (deltoid), **Intradermal** (using an Omega/Tuberculin syringe). * **Dose:** 0.1 ml (0.05 ml for neonates below 4 weeks). * **Diluent:** Normal Saline (Distilled water causes irritation; Dextrose causes death of bacilli). * **The BCG Scar:** It is the only vaccine that leaves a permanent scar, typically forming 6–12 weeks after vaccination. * **Protective Effect:** Highly effective against TB meningitis and miliary TB in children, but has variable efficacy against adult pulmonary TB.

Question 75: Which one of the following is a conjugated vaccine?

A. Hepatitis B
B. Rubella
C. Haemophilus influenza (Correct Answer)
D. Pertussis

Explanation: **Explanation:** The correct answer is **Haemophilus influenzae type b (Hib)**. **1. Why Hib is a Conjugated Vaccine:** The primary virulence factor of *H. influenzae* is its polysaccharide capsule (Polyribosylribitol phosphate - PRP). Polysaccharides are **T-cell independent antigens**, which are poorly immunogenic in children under 2 years of age because their immune systems cannot mount a robust response without T-cell help. To overcome this, the polysaccharide is **conjugated** (chemically linked) to a carrier protein (e.g., Tetanus toxoid or Diphtheria CRM197). This converts the immune response to **T-cell dependent**, leading to the production of high-affinity IgG antibodies and long-term immunological memory. **2. Analysis of Incorrect Options:** * **Hepatitis B:** This is a **Recombinant DNA vaccine** (Subunit vaccine) produced by inserting the HBsAg gene into yeast cells (*Saccharomyces cerevisiae*). * **Rubella:** This is a **Live Attenuated vaccine** (RA 27/3 strain), usually administered as part of the MMR or MR vaccine. * **Pertussis:** The modern version (aP) is an **Acellular vaccine** containing purified components (toxoid, filamentous hemagglutinin), while the older version (wP) is a **Killed/Inactivated vaccine**. **3. NEET-PG High-Yield Pearls:** * **Common Conjugated Vaccines:** Remember the mnemonic **"SPH"** – *Streptococcus pneumoniae* (PCV), *Polysaccharide* (Hib), and *Haemophilus* (Hib), plus Meningococcal vaccine. * **Advantage:** Conjugation induces **mucosal immunity** (IgA), which reduces nasopharyngeal carriage, leading to **herd immunity**. * **Age Factor:** Pure polysaccharide vaccines (like PPV23) are ineffective in infants; conjugated vaccines are the standard for the pediatric immunization schedule.

Question 76: Which of the following is NOT a vaccine-preventable disease?

A. Measles (Correct Answer)
B. Typhoid
C. Hepatitis B
D. Gonorrhea

Explanation: **Explanation** The correct answer is **D. Gonorrhea**. (Note: The prompt incorrectly marked Measles as the correct option; however, medically and for NEET-PG purposes, Gonorrhea is the only disease listed for which no vaccine currently exists.) **1. Why Gonorrhea is the Correct Answer:** *Neisseria gonorrhoeae* possesses high **antigenic variation**, particularly in its pili and Opa proteins. This genetic instability allows the bacteria to constantly change its surface antigens, making it difficult for the immune system to develop lasting immunity and complicating the development of an effective vaccine. Currently, prevention relies on barrier methods and prompt antibiotic treatment. **2. Why the Other Options are Incorrect:** * **Measles (A):** Prevented by the **Live Attenuated** vaccine (Edmonston-Zagreb strain in India). It is a part of the National Immunization Schedule (MR/MMR). * **Typhoid (B):** Multiple vaccines exist, including the **Vi polysaccharide** vaccine, the live oral **Ty21a** vaccine, and the newer **Typhoid Conjugate Vaccine (TCV)**, which provides longer-lasting immunity. * **Hepatitis B (C):** Prevented by a **Recombinant DNA vaccine** (using HBsAg). It is the first "anti-cancer" vaccine as it prevents hepatocellular carcinoma. **Clinical Pearls for NEET-PG:** * **Antigenic Variation:** This is the primary reason why vaccines are unavailable for Gonorrhea, Malaria, and HIV. * **Hepatitis B Vaccine:** Administered at 0, 1, and 6 months. It is the most common vaccine to cause an anaphylactic reaction (due to yeast components). * **Measles Vaccine:** Given at 9 completed months. It must be used within 4 hours of reconstitution to avoid **Toxic Shock Syndrome** caused by *Staph. aureus* contamination.

Question 77: All of the following are true about the BCG vaccine except?

A. WHO recommends the Danish 1331 strain of M. bovis.
B. It is given intradermally.
C. Normal saline is used as a diluent.
D. The site of injection should be cleaned with spirit. (Correct Answer)

Explanation: **Explanation:** The BCG (Bacillus Calmette-Guérin) vaccine is a **live attenuated vaccine** derived from *Mycobacterium bovis*. The correct answer is **Option D** because the site of injection should **never** be cleaned with spirit or any antiseptic. Antiseptics like alcohol/spirit can kill the live bacilli in the vaccine, rendering it ineffective. Instead, the site should be cleaned only with sterile water if necessary and allowed to dry before injection. **Analysis of other options:** * **Option A:** The WHO recommends the **Danish 1331 strain** for global production to ensure uniformity and potency. * **Option B:** It is strictly administered **intradermally** (usually over the left deltoid). This route is essential for the slow release of the antigen and the formation of the characteristic permanent scar. * **Option C:** **Normal Saline (0.9% NaCl)** is the recommended diluent. Distilled water is avoided as it causes irritation and pain due to its hypotonicity. **High-Yield Clinical Pearls for NEET-PG:** * **Dose:** 0.05 ml for neonates (under 1 month) and 0.1 ml for infants above 1 month. * **Reconstitution:** Once reconstituted, the vaccine must be used within **3–6 hours** or discarded to prevent contamination (usually by *Staphylococcus aureus*). * **The "BCG Evolution":** Papule (2-3 weeks) → Vesicle → Pustule → Shallow Ulcer (6-8 weeks) → **Permanent Scar** (12 weeks). * **Protective Effect:** It provides high protection against **Tubercular Meningitis** and **Miliary TB** in children, but its efficacy against adult pulmonary TB varies significantly (0-80%). * **Direct BCG:** BCG given without a prior Mantoux test (standard practice in India).

Question 78: Identify the scientist shown in the image below:

A. John Snow
B. Edward Jenner
C. James Lind
D. Robert Koch (Correct Answer)

Explanation: ***Robert Koch*** - The image shows **Robert Koch**, a renowned German physician and microbiologist, often recognized for his pioneering work in bacteriology. - He is famous for establishing **Koch's postulates**, a set of four criteria designed to establish a causal relationship between a causative micro-organism and an infectious disease. *John Snow* - **John Snow** was a British physician who is considered one of the fathers of modern epidemiology, particularly for his work identifying the source of a cholera outbreak in London. - He is known for using a **spot map** to demonstrate the cluster of cholera cases around a public water pump. *Edward Jenner* - **Edward Jenner** was an English physician and scientist who pioneered the concept of vaccines, creating the world's first vaccine for **smallpox**. - He is often referred to as "the father of immunology" for his groundbreaking work. *James Lind* - **James Lind** was a Scottish surgeon in the Royal Navy who is celebrated for conducting one of the first recorded clinical trials to discover the cause of **scurvy**. - He demonstrated that **citrus fruits** could cure and prevent scurvy, a debilitating disease prevalent among sailors.

Question 79: Which of the following diseases is caused by the virus shown below?

A. Aplastic crisis (Correct Answer)
B. Burkitt lymphoma
C. Primary effusion lymphoma
D. Vesicular vaccination lesion

Explanation: ***Aplastic crisis*** - The image depicts a **bun-shaped, non-enveloped virus** with a **single-stranded DNA genome**, characteristic of **Parvovirus B19**. - **Parvovirus B19** has a strong tropism for **erythroid progenitor cells** in the bone marrow, leading to their lysis and subsequent inhibition of erythropoiesis, which can cause **aplastic crisis**, especially in individuals with underlying hemolytic disorders like sickle cell anemia. *Burkitt lymphoma* - This lymphoma is caused by **Epstein-Barr virus (EBV)**, a **double-stranded DNA herpesvirus**, which has a different morphology than the virus depicted. - EBV is associated with B-cell proliferation, not direct destruction of erythroid precursors which leads to aplastic crises. *Primary effusion lymphoma* - This is a rare B-cell lymphoma associated with **Human Herpesvirus 8 (HHV-8)**, also known as Kaposi's sarcoma-associated herpesvirus. - HHV-8 is a **double-stranded DNA virus** with a different structure and tropism than the parvovirus shown in the image. *Vesicular vaccination lesion* - Vesicular vaccination lesions are typically caused by the **Vaccinia virus**, a **large, complex DNA virus** belonging to the Poxviridae family. - The Vaccinia virus has a distinct brick-shaped morphology and replicates in the cytoplasm, unlike the small, non-enveloped parvovirus shown.

Question 80: The addition of killed Bordetella pertussis microorganisms to diphtheria toxoid enhances the antibody response of the latter because of

A. formation of local granuloma
B. exotoxin of the Bordetella organism
C. additive action of the two antigens
D. endotoxin of the Bordetella organism (Correct Answer)

Explanation: ***endotoxin of the Bordetella organism*** - The **endotoxin** (specifically **lipopolysaccharide** or LPS) of *Bordetella pertussis* acts as an **adjuvant**, stimulating the immune system non-specifically. - This adjuvant effect enhances the antigen presentation and lymphocyte activation, leading to a stronger and more sustained **antibody response** against the diphtheria toxoid. *formation of local granuloma* - While some adjuvants can induce granuloma formation to *sustain* antigen presentation, the primary mechanism of *Bordetella pertussis* *killed organisms* as an adjuvant is not solely due to granuloma formation. - Granuloma formation is more typical of adjuvants like **aluminum salts**, which create a depot effect rather than directly stimulating immune cells via endotoxin. *exotoxin of the Bordetella organism* - **Exotoxins** are typically highly potent toxins produced and secreted by bacteria that can cause specific clinical effects. - The adjuvant effect of killed *Bordetella pertussis* is primarily due to its **cell wall components** (endotoxin), not isolated exotoxins, which would likely be neutralized or removed during vaccine preparation. *additive action of the two antigens* - The enhancement is not merely an "additive action" of two antigens generating separate immune responses. - Instead, the *Bordetella pertussis* components (specifically endotoxin) *potentiate* the immune response to the diphtheria toxoid, acting as an **adjuvant** rather than just another antigen.

Question 81: Vaccines prepared in embryonated hen's eggs are:

A. Rabies
B. Measles (Correct Answer)
C. Rubella
D. Varicella

Explanation: ***Measles*** - The **measles vaccine** is produced using live attenuated virus grown in **chick embryo fibroblast (CEF) cultures** derived from embryonated hen's eggs. - This egg-based production method requires caution in individuals with **severe egg allergies**, though the risk is minimal with modern formulations. - Among the given options, measles is the **classic example** of an egg-substrate vaccine. *Rabies* - Most modern **rabies vaccines** are produced in **human diploid cells (HDCV)** or **purified chick embryo cell (PCEC)** cultures. - While PCEC uses chicken-derived cells, it represents a **cell culture system** rather than direct embryonated egg production. - Not the primary example of egg-based vaccine production. *Rubella* - The **rubella vaccine** component is manufactured using live attenuated virus grown in **human diploid cell cultures** (WI-38 or MRC-5). - **Does not involve** embryonated hen's eggs in its production process. *Varicella* - The **varicella (chickenpox) vaccine** is produced from live attenuated virus grown in **human diploid cell cultures** (MRC-5). - **Does not utilize** embryonated hen's eggs in manufacturing.

Question 82: The process of attenuation can be achieved by all except:

A. Repeated cultures in artificial media
B. Serial passage in an experimental host (Correct Answer)
C. Growing bacteria in unconventional host
D. Growing bacteria in adverse environment

Explanation: ***Serial passage in an experimental host*** - This option is **too vague and non-specific** to reliably achieve attenuation. The term "experimental host" could refer to *any host used in laboratory settings*, including the **natural host** of the pathogen. - Serial passage in the **natural/susceptible host** may actually **maintain or increase virulence** rather than attenuate, as the pathogen continues to adapt to its preferred environment. - **Attenuation requires passage in *unnatural* or *unfavorable* conditions** - not just "an experimental host." *Repeated cultures in artificial media* - This method attenuates pathogens by forcing adaptation to an **in vitro environment**, leading to loss of virulence factors unnecessary for artificial growth but crucial for host infection. - **Examples:** *BCG vaccine* (attenuated *M. bovis* after 230 passages), *Sabin polio vaccine* (passage in monkey kidney cells). - Virulence genes become non-functional over many passages in cell-free media. *Growing bacteria in unconventional host* - Passage in a **non-natural host** (different species) causes loss of virulence factors specific to the original host. - **Example:** *Yellow fever 17D vaccine* (passage in chicken embryos), *measles vaccine* (passage in chicken embryo fibroblasts). - This is a **specific application** of serial passage that reliably achieves attenuation. *Growing bacteria in adverse environment* - Exposure to **suboptimal conditions** (unfavorable temperatures, pH, oxygen tension) causes genetic mutations or loss of virulence plasmids. - **Example:** *Live attenuated influenza vaccine* (cold-adapted strains grown at 25°C instead of 37°C). - Selects for strains prioritizing survival over pathogenesis.

Question 83: Nakayama strain used for which vaccine?

A. Chicken pox
B. Japanese encephalitis (Correct Answer)
C. Typhoid
D. Yellow fever

Explanation: **Correct Answer: Japanese encephalitis** - The **Nakayama strain** is a well-known strain of the **Japanese Encephalitis Virus (JEV)** and was historically used in the development of some of the earliest inactivated JEV vaccines. - While newer vaccine strains like Beijing-1 and SA14-14-2 are more common today, the Nakayama strain played a crucial role in vaccine history and is still referenced in the context of Japanese encephalitis. *Incorrect: Chicken pox* - The vaccine for chickenpox (varicella) typically uses the **Oka strain** of the **Varicella-Zoster Virus (VZV)**, not the Nakayama strain. - Chickenpox is caused by VZV, a herpesvirus, which is distinct from the flavivirus causing Japanese encephalitis. *Incorrect: Typhoid* - Typhoid vaccines are designed to protect against **Salmonella Typhi**, a bacterium, not a virus. - Common typhoid vaccines include inactivated whole-cell vaccines or the Vi polysaccharide vaccine, none of which involve the Nakayama strain. *Incorrect: Yellow fever* - The yellow fever vaccine uses a live-attenuated virus derived from the **17D strain** of the **Yellow Fever Virus (YFV)**. - While both JEV and YFV are flaviviruses, they are distinct, and the Nakayama strain is specific to Japanese encephalitis.

Question 84: Type of immunity conferred on an individual by vaccination is -

A. Artificial active (Correct Answer)
B. Artificial passive
C. Natural passive
D. Natural active

Explanation: ***Artificial active*** - Vaccination introduces **antigens** to the body (artificial means) without causing disease, stimulating the immune system to produce its own antibodies and memory cells. - This type of immunity is considered **active** because the individual's immune system actively participates in generating the protective response, leading to long-lasting immunity. *Artificial passive* - This involves the direct transfer of **pre-formed antibodies** from an external source into an individual to provide immediate, short-term protection. - Examples include antitoxins for tetanus or rabies, where the recipient's immune system does not actively participate in antibody production. *Natural passive* - This occurs when antibodies are transferred naturally from one individual to another, such as from a mother to her fetus across the **placenta (IgG)** or through **breast milk (IgA)**. - It provides temporary protection to the infant without requiring the infant's immune system to produce its own antibodies. *Natural active* - This type of immunity develops when an individual is naturally exposed to a **pathogen** and the immune system responds by producing its own antibodies and memory cells. - This occurs after recovering from an infection, providing long-lasting protection against subsequent encounters with the same pathogen.

Question 85: Which of the following is a cell-fraction derived vaccine?

A. Measles
B. Mumps
C. Rubella
D. Hepatitis-B (Correct Answer)

Explanation: ***Hepatitis-B*** - The Hepatitis B vaccine is a **recombinant vaccine**, produced by inserting the gene for the Hepatitis B surface antigen (HBsAg) into yeast cells. - These yeast cells then produce large amounts of HBsAg, which is purified and used as the vaccine, making it a **cell-fraction derived** or subunit vaccine. *Measles* - The measles vaccine is a **live-attenuated virus vaccine**, meaning it contains a weakened form of the measles virus. - It induces a robust immune response by mimicking natural infection without causing severe disease. *Mumps* - Similar to measles, the mumps vaccine is also a **live-attenuated virus vaccine**, containing a weakened form of the mumps virus. - This type of vaccine provides long-lasting immunity with a single dose. *Rubella* - The rubella vaccine is another example of a **live-attenuated virus vaccine**, using a weakened rubella virus strain. - It is often administered as part of the MMR (Measles, Mumps, Rubella) combination vaccine.

Question 86: The presence of which of the following factors in viruses makes protective vaccines a possibility?

A. Lipids
B. Protein coat (Correct Answer)
C. Enzymes
D. Polysaccharide

Explanation: ***Protein coat*** - The **protein coat** (capsid) of viruses contains **antigenic proteins** that can be recognized by the host immune system. - Vaccines work by exposing the immune system to these viral proteins, stimulating the production of **antibodies** and memory cells for future protection. *Lipids* - While some viruses have a **lipid envelope**, lipids themselves are generally **poor antigens** and do not effectively stimulate a protective immune response on their own. - The immune response against enveloped viruses is primarily directed at the **glycoproteins** embedded within the lipid envelope, not the lipids themselves. *Enzymes* - Viruses contain various enzymes (e.g., reverse transcriptase, RNA polymerase) essential for their replication, but these are typically **intracellular targets**. - **Enzymes** are not usually present on the viral surface in an exposed manner that would consistently trigger a protective antibody response. *Polysaccharide* - **Polysaccharides** are common components of bacterial capsules but are generally **not significant components** of viral structure. - Viruses are primarily composed of nucleic acids and proteins, and the immune response to viruses rarely involves polysaccharides.

Question 87: A microbiologist wants to develop a vaccine for prevention of attachment of diarrhoeagenic E.coli to the specific receptors in the gastro-intestinal tract. All of the following fimbrial adhesions would be appropriate vaccine candidates except -

A. P1-Pili (Correct Answer)
B. K 88
C. CFA-1
D. CS-2

Explanation: ***P1-Pili*** - **P1-pili** (also known as P-fimbriae or Pap-pili) are primarily associated with **uropathogenic *E. coli*** causing **urinary tract infections**, not diarrhoeagenic *E. coli* in the gastrointestinal tract. - A vaccine targeting P1-pili would therefore not be relevant for preventing gastrointestinal attachment. *K 88* - **K88 fimbriae** are well-known **adhesins** found in certain strains of **enterotoxigenic *E. coli*** (ETEC) that colonize the gut and cause diarrhoea, especially in piglets. - Targeting K88 would be an appropriate strategy for a vaccine against diarrhoeagenic *E. coli*. *CFA-1* - **Colonization Factor Antigen I (CFA/I)** is a major **fimbrial adhesin** expressed by human **enterotoxigenic *E. coli*** (ETEC) strains. - CFA/I mediates bacterial attachment to intestinal epithelial cells and is a critical virulence factor, making it a suitable vaccine candidate. *CS-2* - **Colonization Factor Antigen II (CFA/II)**, which includes subunits like **CS-2** (CS for "coli surface"), is another important **fimbrial adhesin** found in human **enterotoxigenic *E. coli*** (ETEC). - CS-2 contributes significantly to ETEC's ability to colonize the small intestine and cause diarrhoea, making it a strong vaccine candidate.

Question 88: Adjuvants given along with antigens are going to

A. reduce the antigenicity
B. increase antigenicity (Correct Answer)
C. reduce the toxigenicity
D. increase toxigenicity

Explanation: ***increase antigenicity*** - Adjuvants are substances added to vaccines to **enhance the immune response** to the co-administered antigen. - They work by various mechanisms, such as forming an antigen depot, activating antigen-presenting cells, and stimulating cytokine production, all leading to a **stronger and more prolonged immune response**. *reduce the antigenicity* - This statement is incorrect as adjuvants are specifically designed to **potentiate, not diminish**, the immune response to an antigen. - Reducing antigenicity would counteract the primary purpose of vaccination, which is to induce protective immunity. *reduce the toxigenicity* - Adjuvants generally do not directly impact the **toxigenicity** of an antigen, which refers to its ability to produce toxins. - While some vaccines detoxify bacterial toxins (e.g., toxoids), this is a separate process from the action of adjuvants that boost immune recognition. *increase toxigenicity* - This is incorrect; adjuvants are not intended to make an antigen more toxic. - Their role is to enhance immunogenicity safely, and increasing toxicity would be counterproductive and harmful.

Question 89: Conjugate vaccines are available for the prevention of invasive disease caused by all of the following except

A. Strep pneumoniae
B. H influenzae
C. N. Meningitidis (group B) (Correct Answer)
D. N. Meningitidis (group C)

Explanation: ***N. Meningitidis (group B)*** - While conjugate vaccines are available for several serogroups of *N. meningitidis*, a **polysaccharide-protein conjugate vaccine** for **serogroup B** has been challenging to develop due to its **less immunogenic capsule** and antigenic mimicry with human tissues. - Currently, available vaccines against **meningococcal serogroup B** are **recombinant protein-based vaccines** (e.g., Bexsero, Trumenba), not traditional polysaccharide-protein conjugate vaccines. *Strep pneumoniae* - **Pneumococcal conjugate vaccines (PCVs)**, such as PCV13 and PCV15, effectively prevent invasive disease caused by *Streptococcus pneumoniae* in both children and adults. - These vaccines conjugate **polysaccharide capsular antigens** to carrier proteins, enhancing immunogenicity, especially in young children. *H influenzae* - The **Haemophilus influenzae type b (Hib) conjugate vaccine** is highly effective in preventing invasive Hib disease, including meningitis and epiglottitis. - This vaccine links the **Hib polysaccharide capsule** to a protein carrier, eliciting a T-cell-dependent immune response. *N. Meningitidis (group C)* - **Meningococcal conjugate vaccines** are widely available and routinely used to prevent invasive disease caused by *Neisseria meningitidis* serogroup C. - These vaccines include **monovalent (e.g., MenC)** and **quadrivalent (e.g., MenACWY)** formulations that target serogroup C.

Question 90: MW vaccine is prepared from:

A. Mycobacterium indicus pranii (Correct Answer)
B. Mycobacterium welchii
C. Mycobacterium bovis
D. Mycobacterium tuberculosis

Explanation: ***Mycobacterium indicus pranii*** - The MW vaccine, also known as the **M. indicus pranii (MIP) vaccine**, is derived from heat-killed *M. indicus pranii* cells. - It is currently being explored as an immunomodulator and vaccine candidate for **leprosy** and **tuberculosis**. *Mycobacterium welchii* - This is an incorrect name; the correct species is *Clostridium perfringens*, previously known as *Bacillus welchii*. - *Clostridium perfringens* is a **gram-positive, anaerobic bacterium** that causes gas gangrene and food poisoning, and is not used in vaccine production for tuberculosis or leprosy. *Mycobacterium bovis* - *Mycobacterium bovis* is the bacterium used to produce the **BCG vaccine** (Bacillus Calmette-Guérin). - The BCG vaccine is primarily used to prevent **tuberculosis**, particularly severe forms in children. *Mycobacterium tuberculosis* - This is the primary causative agent of **tuberculosis** in humans. - A vaccine derived directly from live, virulent *M. tuberculosis* is not used due to its pathogenicity and the risk of causing disease.

Question 91: What is the primary advantage of using live attenuated vaccines?

A. They are effective with single doses
B. They are cheaper to produce
C. They provide stronger, longer-lasting immunity (Correct Answer)
D. They require fewer booster shots

Explanation: ***They provide stronger, longer-lasting immunity*** - Live attenuated vaccines mimic natural infection, leading to a robust immune response involving both **humoral** and **cell-mediated immunity**. - This comprehensive immune activation often results in **lifelong protection** with fewer doses, similar to immunity gained from natural infection. *They are cheaper to produce* - The production of live attenuated vaccines can be complex due to the need for careful **attenuation** and strict quality control, which can be costly. - While some attenuated vaccines might be cost-effective in the long run due to fewer doses, initial production costs are not their primary advantage. *They are effective with single doses* - While many live attenuated vaccines are highly effective with a single dose, not all are; some, like MMR, still require a second dose for optimal protection. - The effectiveness with fewer doses is rather a consequence of the strong immune response, not a standalone advantage over the quality of immunity. *They require fewer booster shots* - This is a direct benefit stemming from the **strong, long-lasting immunity** conferred by live attenuated vaccines. - However, the primary advantage is the quality and duration of the immune response itself, which in turn reduces the need for frequent boosters.

Question 92: In the context of viral diseases, which of the following is a key advantage of live attenuated vaccines over inactivated vaccines?

A. Safe for use in immunocompromised patients.
B. Elicits a robust antibody response without risk of reversion.
C. Preferred for mass vaccination during an outbreak.
D. Induces long-term immunity with a single dose. (Correct Answer)

Explanation: ***Induces long-term immunity with a single dose*** - **Live attenuated vaccines** stimulate a more comprehensive immune response, mimicking natural infection, leading to stronger and **longer-lasting immunity** often with a single dose. - This robust response typically involves both **humoral and cellular immunity**, providing excellent protection. *Safe for use in immunocompromised patients* - **Live attenuated vaccines** are generally **contraindicated in immunocompromised individuals** due to the risk of the attenuated virus replicating and causing disease. - **Inactivated vaccines**, which do not contain live virus, are safer for this population. *Elicits a robust antibody response without risk of reversion* - While live attenuated vaccines do elicit a robust immune response, there is a **small risk of the attenuated virus reverting to a virulent form**, especially in populations with low vaccine coverage. - **Inactivated vaccines** do not carry this risk as the virus is killed and cannot replicate or revert. *Preferred for mass vaccination during an outbreak* - While sometimes used, **live attenuated vaccines** require careful handling, cold chain maintenance, and may have contraindications that complicate mass vaccination efforts during an outbreak. - **Inactivated vaccines** can sometimes be easier to administer during a large-scale outbreak due to their stability and perceived safety profile in diverse populations.

Question 93: Which type of vaccine contains live, attenuated organisms?

A. MMR vaccine (Correct Answer)
B. Hepatitis B vaccine
C. Polysaccharide vaccine
D. Inactivated influenza vaccine

Explanation: ***MMR vaccine*** - The **MMR (Measles, Mumps, Rubella) vaccine** is a classic example of a **live-attenuated vaccine**, using weakened forms of the viruses. - Live-attenuated vaccines generally provide long-lasting immunity with a strong immune response, often after just one or two doses. *Hepatitis B vaccine* - The **Hepatitis B vaccine** is a **recombinant vaccine**, meaning it contains only a specific antigenic component (the surface antigen) of the virus. - It does not contain the whole live or inactivated virus, but rather a manufactured protein that elicits immunity. *Polysaccharide vaccine* - **Polysaccharide vaccines**, such as the pneumococcal polysaccharide vaccine, consist of **purified capsular polysaccharides** from bacteria. - These are **subunit vaccines** that target specific components of the pathogen but do not contain live organisms. *Inactivated influenza vaccine* - The **inactivated influenza vaccine** contains **killed influenza viruses** or viral components that have been chemically or physically inactivated. - Since the viruses are inactivated, they cannot replicate or cause disease, distinguishing them from live-attenuated vaccines.

Question 94: What is the specific protein content of the malaria vaccine RTS,S/AS01?

A. Gametocytic protein
B. Polysaccharide sheath
C. Lipoprotein envelope
D. Sporozoite protein (Circumsporozoite protein) (Correct Answer)

Explanation: ***Sporozoite protein*** - The RTS,S/AS01 vaccine specifically targets the **circumsporozoite protein (CSP)** from the *Plasmodium falciparum* sporozoite stage. - This design aims to prevent **malaria infection** by blocking the parasite before it can infect liver cells. *Gametocytic protein* - Vaccines targeting gametocytic proteins are in development but are designed to block **transmission** of malaria, not prevent initial infection. - They aim to induce antibodies that neutralize gametes within the mosquito, preventing the parasite's sexual reproduction. *Polysaccharide sheath* - **Polysaccharide components** are common in bacterial vaccines (e.g., pneumococcal), but not the primary immunogen in RTS,S, which is a protein-based vaccine. - *Plasmodium* parasites do not possess a significant polysaccharide sheath that serves as a primary vaccine target in this context. *Lipoprotein envelope* - **Lipoprotein envelopes** are characteristic of some viruses (e.g., influenza, HIV), not typically the primary antigen of interest for *Plasmodium falciparum* sporozoites. - While there are lipid components in the parasite, the specific targeted antigen for RTS,S is a **protein**.

Question 95: What is the serum marker after Hepatitis B vaccination?

A. Anti-HBs (Correct Answer)
B. Anti-HBe
C. Anti-HBc
D. HBs antigen

Explanation: **Anti-HBs** - The Hepatitis B vaccine contains **HBsAg** (Hepatitis B surface antigen), which stimulates the immune system to produce **antibodies against HBsAg (Anti-HBs)**. - The presence of **Anti-HBs** indicates successful vaccination and immunity to Hepatitis B infection. *Anti-HBe* - **Anti-HBe** antibodies develop during an acute or chronic Hepatitis B infection and indicate a decrease in viral replication and infectivity. - This marker is not associated with vaccination. *Anti-HBc* - **Anti-HBc** (antibodies against Hepatitis B core antigen) is produced during an active or past Hepatitis B infection, but not as a result of vaccination. - It signifies exposure to the **core protein** of the virus. *HBs antigen* - **HBs antigen (HBsAg)** is a surface protein of the Hepatitis B virus that indicates active acute or chronic infection. - It is the antigen used in the vaccine to stimulate an immune response, but it is not a marker of immunity after vaccination.

Question 96: Capsular polysaccharide derived vaccine is available for all meningococci except?

A. Group C
B. Group B (Correct Answer)
C. Group Y
D. Group A

Explanation: ***Group B*** - The capsular polysaccharide of **Group B meningococci** is composed of **polysialic acid**, which is poorly immunogenic in humans because it structurally mimics human neural cell adhesion molecules. - Due to its **poor immunogenicity** and risk of autoantibody production, traditional polysaccharide vaccines are ineffective against Group B. *Group A* - Polysaccharide vaccines for **Group A meningococci** (e.g., in Menactra, Menveo) are effective in inducing a protective immune response. - Group A is a major cause of meningococcal disease, particularly in the **"meningitis belt"** of sub-Saharan Africa. *Group C* - **Capsular polysaccharide vaccines** are available and effective against Group C meningococcal disease, often included in quadrivalent formulations. - These vaccines elicit a robust **antibody response** against the Group C polysaccharide. *Group Y* - Vaccines containing the **capsular polysaccharide** of Group Y meningococci are effective and commonly included in quadrivalent vaccines. - Group Y is a significant cause of meningococcal disease, particularly in **North America and Europe**.

Question 97: What is the type of vaccine produced from the SA-14-14-2 strain of the Japanese encephalitis virus?

A. Subunit vaccine
B. Inactivated vaccine
C. Killed virus vaccine
D. Live attenuated vaccine (Correct Answer)

Explanation: ***Live attenuated vaccine*** - The **SA-14-14-2 strain** is specifically engineered to be a **weakened, non-pathogenic** form of the Japanese encephalitis virus. - This allows it to replicate in the host without causing disease, stimulating a **strong and long-lasting immune response**. *Inactivated vaccine* - An **inactivated vaccine** uses a whole virus that has been **killed** (inactivated) to prevent it from replicating. - While the SA-14-14-2 strain is used for a vaccine, it is not an inactivated one; it is designed to be **live but attenuated**. *Killed virus vaccine* - A **killed virus vaccine** is another term for an **inactivated vaccine**, where the virus's ability to replicate is destroyed, usually by chemical means. - The SA-14-14-2 vaccine functions by introducing a **live, weakened virus** that can still replicate, rather than a killed one. *Subunit vaccine* - A **subunit vaccine** contains only specific **antigenic components** of the virus, rather than the entire virus. - The SA-14-14-2 vaccine utilizes the **entire virus** in an attenuated form, making it distinct from a subunit vaccine.

Question 98: Pneumococcal vaccine is prepared from ?

A. Cell surface antigen
B. Capsular polysaccharide (Correct Answer)
C. Exotoxin
D. M protein

Explanation: ***Capsular polysaccharide*** - The **polysaccharide capsule** of *Streptococcus pneumoniae* is the primary virulence factor, protecting the bacteria from phagocytosis. - Vaccines, such as **PCV13** (pneumococcal conjugate vaccine) and **PPSV23** (pneumococcal polysaccharide vaccine), are designed targeting these capsular polysaccharides to elicit a protective immune response. *Cell surface antigen* - While bacteria possess various **cell surface antigens**, not all are immunogenic or provide protective immunity as effectively as the capsular polysaccharides for *S. pneumoniae*. - For pneumococcus, the **capsule** is the most critical surface component for vaccine development due to its role in virulence and serotype specificity. *From exotoxin* - *S. pneumoniae* primarily causes disease through its **polysaccharide capsule** and other bacterial components, not through the production of an **exotoxin** that would be targeted by a vaccine. - Vaccines developed from exotoxins (e.g., diphtheria or tetanus toxoids) target specific toxins, which is not the mechanism for pneumococcal vaccines. *From M protein* - **M protein** is a major virulence factor for *Streptococcus pyogenes* (Group A Strep), not *Streptococcus pneumoniae*. - Vaccines targeting M protein are associated with **Group A Streptococcus** infections, for protection against diseases like rheumatic fever.

Question 99: What component is included in the vaccine against N-meningitidis?

A. Killed whole-cell vaccine
B. Capsular polysaccharide (polysaccharide vaccine) (Correct Answer)
C. Outer membrane protein (OMP)
D. Live attenuated vaccine

Explanation: ***Capsular polysaccharide (polysaccharide vaccine)*** - *Neisseria meningitidis* vaccines commonly include **capsular polysaccharides** from different serogroups (A, C, Y, W-135) to elicit a protective immune response. - These polysaccharides act as antigens, stimulating the production of **antibodies** that can neutralize the bacteria. - **Conjugate vaccines** combine polysaccharides with carrier proteins to improve immunogenicity, especially in infants and young children. *Killed whole-cell vaccine* - **Killed whole-cell vaccines** are not used for *N. meningitidis* due to potential reactogenicity and the availability of more effective targeted antigens. - **Polysaccharide and conjugate vaccines** are the established formulations for meningococcal disease prevention. *Outer membrane protein (OMP)* - **Outer membrane proteins (OMPs)** are specifically used in **serogroup B vaccines** (e.g., Bexsero, Trumenba) due to the poor immunogenicity of the serogroup B polysaccharide capsule. - However, for serogroups A, C, Y, and W-135, **capsular polysaccharide** remains the primary vaccine component. *Live attenuated vaccine* - **Live attenuated vaccines** are not used for *N. meningitidis* as they pose risks of reversion to virulence and are unnecessary given the effectiveness of polysaccharide-based vaccines. - Meningococcal vaccines rely on **subunit approaches** (polysaccharides, conjugates, OMPs) rather than live organisms.

Question 100: Which strain of the rabies virus is primarily used to produce the rabies vaccine?

A. Wild strain
B. Street strain
C. Fixed strain (Correct Answer)
D. Live attenuated strain

Explanation: ***Fixed strain*** - The **fixed strain** of rabies virus is attenuated through serial passages in animal brains or cell cultures, making it less virulent while retaining immunogenicity. - This attenuated strain is crucial for vaccine production as it can induce an immune response without causing disease. *Wild strain* - The **wild strain** or **sylvatic strain** refers to the rabies virus circulating naturally in animal populations. - It is highly virulent and pathogenic, making it unsuitable for vaccine production due to the risk of causing disease. *Street strain* - The **street strain** is another term used to describe the wild, unadapted form of the rabies virus. - This strain causes the clinical manifestation of rabies in infected animals and humans and is therefore too dangerous to be directly used in vaccine manufacturing. *Live attenuated strain* - While rabies vaccines are indeed a form of attenuated vaccine, the specific and historical term used for the attenuated virus strain adapted for vaccine production is the **fixed strain**, not just a generic "live attenuated strain." - **Live attenuated vaccines** contain weakened forms of the virus, but the term "fixed strain" specifically refers to the rabies virus that has been serially passaged to achieve this attenuation.

Question 101: Recipients of meningococcal polyvalent vaccine are not protected from which serogroup of Neisseria meningitidis with the vaccine available today?

A. Serogroup C
B. Serogroup Y
C. Serogroup B (Correct Answer)
D. Serogroup A

Explanation: ***Serogroup B*** - The **meningococcal polyvalent vaccine** (e.g., MenACWY) primarily targets serogroups A, C, W-135, and Y. - **Serogroup B** is not adequately covered by these polysaccharide-based vaccines due to its capsular polysaccharide being poorly immunogenic and structurally similar to human host antigens, requiring different vaccine technologies (e.g., recombinant protein vaccines like Bexsero and Trumenba). *Serogroup A* - **Serogroup A** is one of the target serogroups included in the standard **meningococcal polyvalent vaccines** (MenACWY), offering protection against this specific strain. - Vaccines for serogroup A have been crucial in controlling epidemics, particularly in the African meningitis belt. *Serogroup C* - **Serogroup C** is another key component covered by the **meningococcal polyvalent vaccines** (MenACWY), providing protection against this common cause of meningococcal disease. - Conjugate vaccines against serogroup C have significantly reduced disease incidence in many countries. *Serogroup Y* - **Serogroup Y** is one of the serogroups included in the **meningococcal polyvalent vaccines** (MenACWY), conferring protection against infections caused by this strain. - Serogroup Y is increasingly recognized as a cause of meningococcal disease in certain regions, including the United States.

Question 102: Which strain is used in the Mumps vaccine?

A. Jeryl Lynn strain (Correct Answer)
B. Edmonston Zagreb strain
C. RA 27/3 strain
D. Oka strain

Explanation: ***Jeryl Lynn strain*** - The **Jeryl Lynn strain** is the most commonly used and safest viral strain for the mumps vaccine, having been isolated in 1963. - This strain is known for its **attenuation** (weakened form) without losing its immunogenicity, providing effective protection against mumps. *Edmonston Zagreb strain* - The **Edmonston-Zagreb strain** is primarily used in some measles vaccines, not mumps vaccines. - It is a highly effective measles vaccine strain, but its application is specific to measles immunization. *RA 27/3 strain* - The **RA 27/3 strain** is exclusively used in the rubella vaccine to protect against rubella (German measles). - It is a live-attenuated virus that elicits a strong immune response against rubella. *Oka strain* - The **Oka strain** is the main attenuated strain used in the varicella vaccine to prevent chickenpox. - It is derived from a wild-type varicella-zoster virus and is effective in preventing or mitigating chickenpox.

Question 103: Meningococcal vaccine is prepared from which of the following organisms?

A. Mycobacterium tuberculosis
B. Mycobacterium bovis
C. Neisseria meningitidis (Correct Answer)
D. Clostridium perfringens

Explanation: ***Neisseria meningitidis*** - The meningococcal vaccine is specifically designed to prevent infections caused by **_Neisseria meningitidis_**, which is the primary cause of meningococcal meningitis and sepsis. - The vaccine typically targets the **polysaccharide capsule** of specific serogroups of _N. meningitidis_, such as A, C, W, and Y, or includes components for serogroup B in newer vaccines. *Mycobacterium bovis* - _Mycobacterium bovis_ is the causative agent of **bovine tuberculosis** and can also cause tuberculosis in humans, mainly through the consumption of contaminated dairy products. - The **BCG vaccine** (Bacillus Calmette-Guérin) is derived from an attenuated strain of _Mycobacterium bovis_ and is used to prevent tuberculosis, not meningococcal disease. *Mycobacterium tuberculosis* - _Mycobacterium tuberculosis_ is the bacterium responsible for causing **tuberculosis** in humans, a respiratory disease primarily affecting the lungs. - There is currently no widely available vaccine specifically derived from _M. tuberculosis_ for human use; prevention relies on identifying and treating infected individuals and using the BCG vaccine. *Clostridium perfringens* - _Clostridium perfringens_ is a bacterium known to cause **gas gangrene** (a severe form of soft tissue infection) and various types of food poisoning. - While it can produce toxins and cause significant disease, there is no vaccine available or commonly used for _Clostridium perfringens_ infections in humans.

Question 104: From which strain of virus is the rabies vaccine prepared?

A. Street virus
B. Fixed Virus (Correct Answer)
C. Wild virus
D. Pasteur virus

Explanation: ***Fixed Virus*** - The rabies vaccine is prepared from **fixed virus strains**, which are **attenuated** forms of the rabies virus that have lost their pathogenicity for humans through serial passages in animals or cell cultures. - This attenuation allows the virus to induce an immune response without causing disease, making it safe and effective for vaccination. - Examples include **Pitman-Moore strain**, **Flury strain (HEP/LEP)**, and **SAD strain**. *Street virus* - The **street virus** is the term used for the **wild-type rabies virus** as it occurs naturally in infected animals and causes clinical rabies disease. - Due to its high pathogenicity and ability to cause lethal infection, the street virus is **not used** for vaccine production. *Wild virus* - **Wild virus** is another term referring to the naturally occurring, **virulent rabies virus** found in infected animals. - Like the street virus, it is too pathogenic to be used directly in vaccine preparation. *Pasteur virus* - While **Louis Pasteur** pioneered rabies vaccination, "Pasteur virus" is not a standard terminology for vaccine strains. - The term **"fixed virus"** specifically denotes laboratory-adapted, attenuated strains regardless of their origin.

Question 105: Which of the following is a live vaccine?

A. Salk polio
B. Sabin polio (Correct Answer)
C. Meningococci
D. KFD vaccine

Explanation: ***Sabin polio*** - The Sabin polio vaccine is an **oral polio vaccine (OPV)** that contains **live, attenuated (weakened) poliovirus**. - It induces a strong immune response, including mucosal immunity, which helps prevent transmission of the wild virus. *Salk polio* - The Salk polio vaccine is an **inactivated polio vaccine (IPV)**, meaning it contains **killed poliovirus**. - Unlike live vaccines, inactivated vaccines cannot replicate in the body and do not carry a risk of reversion to virulence. *KFD vaccine* - The KFD (Kyasanur Forest Disease) vaccine is an **inactivated viral vaccine**. - It is prepared from the brains of infected mice or chick embryos and is used to protect against the KFD virus. *Meningococci* - Meningococcal vaccines are typically **polysaccharide or conjugate vaccines**, composed of components of the bacterial capsule, not live organisms. - These vaccines target *Neisseria meningitidis* and do not contain live attenuated bacteria.

Question 106: Salk vaccine is a:

A. Live vaccine
B. Inactivated vaccine (Correct Answer)
C. Attenuated vaccine
D. Inactivated toxin

Explanation: ***Inactivated vaccine*** - The **Salk vaccine** is an **inactivated poliovirus vaccine (IPV)** that uses chemically inactivated (killed) wild-type poliovirus strains. - This inactivation process renders the virus unable to replicate or cause disease, while still retaining its **antigenicity** to elicit an immune response. - The Salk vaccine is administered by **intramuscular injection** and provides systemic immunity. *Live vaccine* - **Live vaccines** contain live, replicating organisms that are either attenuated (weakened) or fully virulent. - The **Sabin vaccine** (oral poliovirus vaccine - OPV) is an example of a live attenuated vaccine for polio, not the Salk vaccine. - The Salk vaccine contains completely inactivated virus and is therefore not a live vaccine. *Attenuated vaccine* - **Attenuated vaccines** contain live but weakened forms of the pathogen, which can replicate to a limited extent in the host without causing disease. - Examples include MMR, varicella, and the **Sabin vaccine** for polio. - The Salk vaccine uses **inactivated virus**, not attenuated virus, making this option incorrect. *Inactivated toxin* - An **inactivated toxin**, also known as a **toxoid vaccine**, is derived from bacterial toxins that have been rendered harmless but still stimulate an immune response. - Examples include **tetanus and diphtheria vaccines**, which target bacterial toxins rather than whole viruses. - The Salk vaccine targets the **poliovirus itself**, not a toxin produced by the virus.

Practice by Chapter

Principles of Immunization

Practice Questions

Types of Vaccines

Practice Questions

Vaccine Development and Production

Practice Questions

Routine Immunization Schedule

Practice Questions

Adverse Events Following Immunization

Practice Questions

Cold Chain and Vaccine Delivery

Practice Questions

New Vaccine Technologies

Practice Questions

Vaccination in Special Populations

Practice Questions

Herd Immunity and Population Protection

Practice Questions

Anti-vaccination Movement and Hesitancy

Practice Questions

National Immunization Programs

Practice Questions

Future of Vaccines

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free